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1 Abstract 
 
Angiogenesis is a complex developmental process that requires a coordinated migration and 
morphological adaptation of endothelial cells. During blood vessel sprouting, endothelial cells 
need to orchestrate biochemical signals alongside with mechanical guidance cues originating 
from the cellular microenvironment. Due to the pathophysiological relevance of angiogenesis, 
the relevant biochemical signaling pathways and associated growth factors have been well 
characterized over the past decades. However, the regulatory aspects underlying 
mechanosensing in angiogenesis are poorly understood to date. Recent work promoted the 
two actin-dependent transcription factors MRTF and YAP as potential key players in regulating 
vessel growth in response to cytoskeletal remodeling. 
In the first part of this thesis, a micropatterning approach was used to dissect the regulatory 
triggers of MRTF and YAP in endothelial cells. By mimicking microenvironmental aspects of 
angiogenesis within a spatiotemporally controllable experimental setting, changes in the 
provided adhesive area and the loss of cell-cell contacts were identified as key regulatory 
parameters regarding MRTF and YAP transcriptional activity in HUVEC. In contrast, 
endothelial cell shape only marginally affected nuclear levels of both transcription factors at 
steady state conditions. By analyzing the nuclear redistribution of MRTF and YAP under 
laminar shear stress conditions and during cell migration across dumbbell-shaped 
microstructures, it was furthermore demonstrated that MRTF and YAP exhibit differential 
activation kinetics. The resulting regulatory concept was successfully recapitulated in 
angiogenic model systems in vitro and in vivo. 
In the second part of the project, the influence of natural actin binding compounds on gene 
transcription, in particular regarding MRTF and YAP activity, was investigated. It was shown 
that the actin stabilizer Miuraenamide A and the destabilizing compound Latrunculin B 
adversatively shift the concentration of nuclear actin. However, intranuclear aspects of 
transcriptional regulation remained largely unaffected by either compound, thus pointing to the 
direction that actin binding compounds predominantly regulate transcription via the cytoplasm. 
The polymerizing compound Miuraenamide A was subsequently identified as an inducer of 
MRTF nuclear translocation and SRF target gene expression. In contrast, the transcription 
factor YAP could not be activated by compound-induced actin polymerization. Mechanistically, 
this was owed to the failing abrogation of AMOTp130-mediated YAP inhibition through 
Miuraenmide A. 
In sum, the present work provides a characterization of the regulatory aspects and functional 
implications underlying MRTF and YAP activity in endothelial cells. It further promotes natural 
actin binding compounds as a valuable tool to bidirectionally shift nuclear actin levels and to 
selectively target actin-dependent signaling pathways.
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2 Introduction 
 
2.1 Angiogenesis in health and disease 
2.1.1 Basic aspects of angiogenesis 
 
Being required for the transport of nutrients, oxygen and biochemical messenger substances 
such as hormones, blood vessels are a fundamental part of the human body and most other 
animal organisms. The blood stream further provides a gateway for immune cells and 
contributes to the maintenance of body temperature and pH homeostasis 1. In the developing 
embryo a de novo circulatory system is formed by endothelial precursor cells, so-called 
angioblasts, in a process termed vasculogenesis. In contrast, angiogenesis describes the 
sprouting of blood vessels from a pre-existing vascular network, which is physiologically 
relevant in adult tissue during hypoxic adaptation, wound healing and throughout the ovarian 
cycle 2. The angiogenic process is characterized by a spatiotemporally coordinated migration 
and morphological adaptation of endothelial cells (ECs), which form the inner layer of blood 
vessels. In response to extracellular growth factors such as VEGFs (vascular endothelial 
growth factors), ECs start to locally degrade the surrounding basement membrane by secretion 
of matrix metalloproteases. To ensure a coordinated sprout formation ECs subsequently 
differentiate into guiding, filopodia-rich tip cells and lumen forming stalk cells. This process is 
tightly regulated by a negative feedback mechanism involving VEGF signaling and the closely 
associated DLL4-Notch pathway 3.  
 
2.1.2 Pathophysiological role of angiogenesis 
 
Abnormal angiogenesis is a promoting and sometimes causative factor in various diseases. 
Insufficient or inadequate blood vessel formation provokes ischemia in neurodegenerative 
diseases, diabetes and myocardial infarction. On the other hand, excessive angiogenesis and 
neovascularization contributes to inflammatory and retinal diseases, such as age-related 
macular degeneration 2. Moreover, the increased energy demand of malignant tissues triggers 
tumor-associated vascular growth, making angiogenesis a hallmark of cancer development 
and progression 4. 
The pathophysiological relevance of angiogenesis gave rise to several targeting approaches 
and the development of both pro- and anti-angiogenic pharmaceuticals 5. Although promising 
candidates, such as the VEGF decoy receptor Aflibercept, have been successfully brought into 
clinical application, compensatory mechanisms and a potentially pro-metastatic long-term 
response were severely limiting the initial expectations in recent years 6. Thus, the evaluation 
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of novel targeting approaches beyond the inhibition of angiogenic growth factor signaling is of 
significant interest.  
 
2.2 Mechanosensitive gene regulation: feel the force 
2.2.1 General mechanisms and physiological relevance of mechanosensing 
 
In order to successfully establish, and to guide vascular sprouts, endothelial tip and stalk cells 
need to integrate biochemical signals alongside with mechanical cues originating from a 
constantly changing microenvironment. The translation of mechanical information into an 
adapted gene expression profile, a process termed mechanosensing, is of fundamental 
importance not only in angiogenesis but also during other developmental events such as early 
embryogenesis and nervous system development 7.  
         
 
Figure 2-1 | Principle mechanisms of mechanosensitive signal transduction 
  
To enable a precisely regulated transcription of mechanosensitive genes, mechanical 
information is transmitted to the nuclear compartment via a variety of different mechanisms. 
First, extracellular physical force can alter the conformation of nuclear pores or membrane 
proteins, such as mechanosensitive ion channels and phospholipases, which subsequently 
activate classical downstream effectors like MAPK signaling 8,9. Second, the nuclear envelope 
is coupled to the cytoskeleton via so-called LINC (linker of the nucleoskeleton and the 
cytoskeleton) complexes 10,11. The resulting structural network acts as a direct force 
transmission route, which ultimately regulates chromatin organization in response to 
mechanical stress and nuclear deformation 12. A third option is provided by the family of actin-
dependent, mechanosensitive transcription factors 13. In principle, the subcellular localization 
2 Introduction 
  5 
of these proteins is coupled to the polymerization state of actin. Thus, they are either sensitive 
to the amount of (globular) G-actin or that of (filamentous) F-actin. Two prominent examples 
of actin-dependent, mechanosensitive transcription factors are introduced in the following 
sections. 
 
2.2.2 The MRTF-SRF axis: a direct sensor of actin polymerization 
 
Serum response factor (SRF) was first identified in 1986 by the group of Richard Treisman, 
who described it as a protein 
mediating the transcriptional 
response to serum factors 14. In the 
following years, it was found that 
actin dynamics are one of the key 
regulators of SRF activity 15. The 
missing link between actin 
polymerization and SRF activity 
was finally established by the 
identification of myocardin-related 
transcription factors (MRTFs, also 
named MKL1 or MAL) in 2003 16.  
Mechanistically, the two MRTF 
isoforms MRTF-A and MRTF-B 
bind to G-actin via N-terminal 
RPEL motifs and are thereby 
sequestered in the cytoplasm. 
Upon actin polymerization the binding to G-actin is released and MRTF translocates to the 
nucleus (Fig. 2-2). Being a transcriptional co-activator, MRTF enhances the activity of SRF at 
the serum response element (SRE) promotor. In 2007, the Vartiainen lab proved that 
subcellular localization and activity of MRTF is regulated by both cytoplasmatic and nuclear 
actin 17. Furthermore, it was found that binding of nuclear G-actin triggers MRTF nuclear 
export. In turn, nuclear actin polymerization, and therefore depletion of nuclear G-actin, 
stimulates MRTF-SRF activity 18. 
As depicted in Fig. 2-2, MRTFs are not the only coactivators of SRF, since ternary complex 
factors (TCFs) compete with MRTFs for the binding of SRF at CArG domains. However, TCFs 
are activated downstream of the small GTPase Ras and therefore not considered as 
mechanosensitive transcription factors.  
Figure 2-2 | The serum response factor pathway 
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A systematic target gene analysis in 2006 has identified the SRF pathway as a fundamental 
regulator of cytoskeletal and adhesive genes 19,20. Therefore, SRF signaling plays an important 
role in cellular processes associated to growth, migration and development 21-24. The 
pathophysiological aspects of inadequate SRF activity, in particular concerning angiogenesis, 
are described in section 2.2.4. 
 
2.2.3 The Hippo-YAP/TAZ pathway: a major mechanosensitive hub 
 
The Hippo pathway was initially discovered in genetic mosaic screens for tumor suppressor 
genes in Drosophila 25-27. In the following years, it became clear that the Hippo pathway is a 
highly conserved kinase cascade regulated similarly in insects and mammals. As 
schematically shown in Fig. 2-3, the mammalian Hippo kinase ortholog MST1/2 acts as an 
upstream regulator of the serine/threonine kinases Lats1 and 2. In turn, Lats1/2 phosphorylate 
the two closely related transcription factors YAP (yes-associated protein) and TAZ 
(transcriptional coactivator with PDZ-
binding motif), thereby inhibiting their 
nuclear translocation and the 
subsequent expression of target genes. 
Mechanistically, the cytoplasmatic 
sequestration of phosphorylated 
YAP/TAZ is mediated by an interaction 
with 14-3-3 proteins. 
YAP and TAZ turned out to be 
fundamental regulators of organ size, 
cell differentiation, proliferation and 
apoptosis 28,29. However, although the 
core kinase cascade of Hippo-YAP/TAZ 
is well described, the relevant 
extracellular regulators are poorly 
characterized. The actin cytoskeleton 
has recently moved into the focus of 
interest, since it could provide a 
common downstream element 
integrating both G-protein coupled receptors 30 and cell polarity based signaling 31. In addition, 
a regulatory mechanism independent from canonical Hippo signaling is being discussed as 
well. In any case, actin appears to be one, if not the key upstream regulator of Hippo-YAP/TAZ, 
thus rendering this signaling cascade a major mechanosensitive pathway. 
Figure 2-3 | Upstream regulators of mammalian YAP/TAZ 
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2.2.4 MRTF and YAP in angiogenesis: happy together? 
 
As mentioned before, angiogenesis is a complex developmental process that involves the 
coordinated migration and proliferation of endothelial cells. Since cell division and movement 
fundamentally rely on actin dynamics, it is reasonable to assume that mechanosensitive 
transcription factors influence angiogenesis.  
Several studies in the lab of Cláudio A. Franco have demonstrated that MRTF-SRF is required 
for sprouting angiogenesis 32, vascular branching 33 and tip cell invasion 34. In turn, an 
endothelial ablation of MRTF-SRF in adult mice provokes intracerebral hemorrhagic stroke 35. 
In a similar experimental setting, vascular disease phenotypes were observed in murine 
retinae 36. Similar to MRTF-SRF, the Hippo-YAP/TAZ cascade is also functionally required for 
angiogenesis. For instance, Wang et al. have recently demonstrated that YAP and TAZ act 
upstream of VEGF-VEGFR2 signaling 37. Moreover, YAP contributes to vessel maintenance 38 
and regulates the cell contact-mediated expression of angiopoetin-2 39. 
Accumulating evidence suggests that the actin-dependent, mechanosensitive transcription 
factors MRTF and YAP are required for angiogenesis. However, most of these studies focus 
on knock-out settings and their functional consequences. In turn, little is known about the 
regulatory aspects underlying MRTF and YAP activity in endothelial cells. Moreover, the 
common influence of actin polymerization on MRTF and YAP raises the question whether 
these two pathways act in concert or serve distinct functions in the regulation of 
angiogenesis 40. Both of these aspects need to be answered in order to evaluate the potential 
of MRTF and YAP as possible target structures for pro- or antiangiogenic therapy strategies. 
 
2.3 Nuclear actin and its novel role as a transcriptional regulator 
2.3.1 Actin in the nucleus: an emerging field of research 
 
From a historical perspective, actin was long thought to be exclusively present in the 
cytoplasmatic compartment. As it is one of the most abundant proteins in the cell, the potential 
identification of actin in nuclear extracts or intranuclear protein complexes was prone to 
cytoplasmatic contamination. Moreover, the physiological significance of in vitro findings was 
frequently questioned 41. Due to progress in the visualization of nuclear actin 42,43, the research 
field has picked up speed in recent years. Today, it is known that cytoplasmatic ß-actin 
monomers enter the nucleus in an active transport process mediated by importin-9 44. Owed 
to the lack of a nuclear localization sequence (NLS), actin is only imported when bound to 
NLS-containing cofilins. Conversely, excess actin is exported from the nuclear compartment 
in a profiling-bound state via exportin-6 45.  
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Under specific conditions, such as growth factor stimulation 46, or in response to DNA damage 
47,48, nuclear actin can polymerize into filamentous structures. Moreover, intranuclear actin 
polymerization has been shown to stabilize the nucleus against gravity in Xenopus oocytes 49. 
However, classical cytoplasmatic roles of actin, such as cell migration or vesicular transport, 
cannot be applied to the nucleus. Therefore, the nuclear role of polymerized actin and F-actin 
binding proteins, such as myosin I, remains largely elusive to date 50.  
Other than its polymerized counterpart, monomeric nuclear actin is fundamentally required for 
gene expression 51. The contribution of actin monomers to transcriptional regulation will be 
introduced in the following section. 
 
2.3.2 Monomeric nuclear actin acts as a transcriptional all-rounder 
 
As described in section 2.2, cytoplasmatic actin can serve as a force-sensitive element that 
translates extracellular mechanical information into biochemical signals, and ultimately into an 
adapted gene expression profile. However, the influence of actin on gene transcription is not 
restricted to the cytoplasm. Connected to its long-debated presence in mammalian cell nuclei 
(section 2.3.1), nuclear actin has begun to emerge as a versatile regulator of gene expression. 
The involvement of nuclear actin in transcriptional regulation was first suggested in the early 
1980s 52. In 1984, Scheel et al. microinjected actin binding proteins into the nuclei of living 
Pleurodeles oocytes and demonstrated an inhibition of transcription 53. In the years to follow, 
it became clear that actin monomers are subunits of ATP-dependent chromatin remodeling 
complexes, such as INO80, BAF and SWR1 54,55. Although the precise role of actin in these 
complexes is still unclear, it has been shown that actin forms a functional module with the two 
actin-related proteins Arp4 and Arp8 56. Being closely associated with chromatin remodeling, 
also epigenetic histone modification is influenced by nuclear actin. Initially, actin was identified 
as a subunit in the NuA4 histone acetyltransferase complex in yeast 57. More recently, studies 
reported a role of nuclear actin in regulating class I histone deacetylases 58. 
Next to its influence on chromatin-associated processes, a second feature of monomeric 
nuclear actin is delineated by its association with RNA polymerases. In 2004, two independent 
groups reported that nuclear actin binds RNA polymerases I, II and III 59-61. Apart from its 
functional requirement for initiation and elongation 62, actin is also bound to a subset of pre-
mRNA binding proteins 63, thereby covering the entire transcriptional process from gene 
activation to nuclear export of the mature mRNA. 
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2.4 Tools to study mechanosensitive signaling in endothelial cells 
2.4.1 Natural actin binding compounds: the pharmacological toolbox in actin research 
 
Actin binding compounds are a frequently used tool in cell biology. Compounds with cytotoxic 
activity against the cytoskeleton have been isolated from different organisms ranging from 
fungi, algae, bacteria and marine sponges to terrestrial plants. Thus, the vast majority of this 
substance class is composed of natural products 64. 
Actin targeting compounds are classified into filament-destabilizing (depolymerizing) and 
filament-stabilizing (polymerizing) compounds. The latter class almost exclusively comprises 
cyclic peptides and depsipeptides. A well-known example of this group is phalloidin, a cyclic 
peptide synthesized by the ‘Death Cap’ mushroom Amanita phalloides 65. To stabilize actin 
filaments in live cells, the membrane permeable compound Jasplakinolide was preferably 
used. In 2006, Miuraenamide A, a cyclic depsipetide isolated from the halophilic 
myxobacterium Paraliomyxa miuraensis, was discovered as a novel, more potent alternative 
to the structurally related Jasplakinolide 66,67.  
 
 
 
 
 
 
 
 
 
 
 
 
Other than actin stabilizing compounds, depolymerizing substances are a heterogeneous 
class which follows different modes of filament destabilization. The most widely used 
depolymerizing compound is Latrunculin B, a thiazolidine ring containing substance isolated 
from the Red Sea sponge Negombata magnifica 68. Mechanistically, Latrunculin B binds to the 
ATP-binding cleft of actin, thereby stabilizing the monomeric state 64. Other examples of actin 
depolymerizing compounds include the barbed end targeting substance Swinholide A 69 and 
the macrolides Chivosazole A and F 70.   
Actin binding compounds are well-characterized in terms of their basic functional effects on 
cell migration, proliferation or apoptosis. However, their influence on mechanosensitive gene 
expression remains largely elusive to date. In particular, it has not been described whether 
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Figure 2-4 | Chemical structures of different natural actin binding compounds 
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these compounds are able to regulate mechanosensitive transcription factors or actin-
dependent transcriptional processes in the nucleus. 
 
2.4.2 Micropatterning allows to study the cytoskeleton in a defined microenvironment 
 
The cellular microenvironment is a highly structured biological system providing numerous 
chemical and mechanical signaling cues. Parameters such as extracellular matrix (ECM) 
architecture, composition and stiffness are sensed by the cell during integrin- or cadherin-
based cell adhesion 71. As a consequence, the actin cytoskeleton is remodeled to adapt to the 
surrounding ECM. Due to their uniform and static properties, standard cell culture surfaces can 
hardly reflect a given in vivo microenvironment 72.  
Micropatterning techniques have emerged as a novel possibility to study distinct aspects of 
cellular behavior in a tailored microenvironment. Although first micropatterning techniques 
were described decades ago, they only recently became available for broad application 72. 
Besides laser- and photo-patterning based methods, microcontact printing provides an easy-
to-access and thus widely used alternative (Fig. 2.5 and section 6.2.2).   
 
 
 
 
 
 
 
 
 
Micropatterning approaches have been employed to study various aspects of endothelial cell 
morphology and functional behavior in the context of angiogenesis 73,74. For example, 
Vartanian et al. mimicked cell elongation in response to fluid shear stress by culturing ECs on 
stretched, rectangular patterns 75. In our lab, microcontact printing was used to simulate 
endothelial cell migration in low-adhesive, fibrillary matrices such as Collagen I 76. Due to their 
ability to spatiotemporally control microenvironmental parameters, microstructured surfaces 
provide an interesting experimental tool to study the regulation of mechanosensitive signaling 
pathways, such as MRTF-SRF or Hippo-YAP/TAZ. 
A D B C 
Figure 2-5 | Overview of different micropatterning techniques. (A) Microcontact printing: micro-features are 
transferred with ECM-coated polydimethylsiloxane (PDMS) stamps onto the uncoated surface of a cell culture dish. 
Intermediate spaces are blocked with a hydrophilic polymer. (B) Photo-patterning: the micropattern is introduced 
by selective detachment of the hydrophilic polymer under light exposure in combination with a photomask. (C) 
Laser-patterning: Instead of a photomask (B), pulsed laser is used for polymer detachment. (D) Single Endothelial 
cells in unconfined culture (top) or on microstructured surfaces (bottom). 
2 Introduction 
  11 
2.5 Aim of the study 
 
Angiogenesis is crucially involved in the development and progression of cancer, the leading 
cause of death worldwide. The biochemical key players involved in blood vessel sprouting are 
well-characterized. However, the regulatory aspects and the targeting potential associated to 
mechanosensitive signaling pathways are poorly understood to date.  
The aim of this study was to investigate the physiological regulation of the mechanosensitive 
transcription factors MRTF-A and YAP in endothelial cells. In addition, the influence of natural 
actin binding compounds on actin-dependent gene transcription and nuclear actin was 
investigated. 
To provide a clear structure, the results section is subdivided into two parts.  
 
Part I 
 
The aim of the first project was to characterize the physiological regulation of MRTF and YAP 
in the context of angiogenesis. The precise goals can be described as follows:  
 
• Design and validate a set of micropatterns to study the mechanosensitive regulation of 
MRTF-A and YAP in primary endothelial cells 
• Elucidate the regulatory triggers and kinetics underlying MRTF-A and YAP activity in 
endothelial cells 
• Verify the acquired data in angiogenic model systems 
 
 
Part II 
 
The aim of the second project was to evaluate the potential of actin binding compounds to 
target mechanosensitive gene regulation in endothelial cells. Therefore, the actin binding 
compounds Miuraenamide A and Latrunculin B were characterized according to their influence 
on the following aspects: 
 
• Cytoplasmatic regulation of MRTF-A and YAP activity 
• Actin-dependent transcriptional regulation in the nucleus 
• Structural properties and concentration of intranuclear actin 
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3 Results I: Regulation of MRTF-A and YAP in angiogenesis 
 
3.1  Mechanical aspects of MRTF-A and YAP activity in HUVEC 
3.1.1 Design of micropatterns to study mechanosensitive signaling cues 
 
The sprouting of blood vessels is a mechanically complex process characterized by the 
simultaneous change of several cellular and microenvironmental parameters. In order to 
spatiotemporally dissect this process into controllable substeps, we designed the set of 
micropatterns depicted in Fig. 3-1A. A 2500 µm2 sized microadhesive square, which roughly 
reflects the area that is normally occupied by unconfined endothelial cells in culture, was 
chosen as a common element present in every set of patterns.  
 
 
 
Figure 3-1 | Microcontact printing as a tool to study mechanosensitive signaling cues in endothelial cells. 
(A) Based on a 50 x 50 µm square domain as a common starting point (center), four different sets of micropatterns 
were generated to study the regulatory triggers of MRTF-A and YAP in endothelial cells. (B) Different pattern 
geometries are associated with changes in cellular F- / G-actin ratio. Endothelial cells were cultured on the 
micropatterns depicted in (A) and after 20 h co-stained for F-actin (phalloidin) and G-actin (DNAse I). F- / G-actin 
ratios were calculated in terms of total intensity relation between the phalloidin and DNAseI signal and are 
expressed as normalized fractions of the 2500 µm2 square present in each set. Statistical significance was 
determined by Sidak corrected one-way ANOVA test, p < 0.05. 
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Starting from this reference square, nuclear levels of MRTF-A and YAP could subsequently be 
studied in response to defined alterations of cell morphology and extracellular parameters such 
as the provided adhesive surface area. 
To ensure that the resulting patterns cover a size range that is capable of imposing distinct 
mechanical challenges on our cells, we analyzed the impact of pattern geometry on cellular F-
actin / G-actin ratio via co-staining of both fractions with phalloidin and DNAseI 77,78. We found 
that, normalized to the reference square, F- / G-actin ratios varied between 80 - 120% within 
the designed set of micropatterns (Fig. 3-1B). 
 
3.1.2 Cell-cell contacts regulate subcellular localization of MRTF-A and YAP 
 
In order to analyze the impact of cell-cell contacts on endothelial MRTF-A and YAP activity, 
we cultured single endothelial cells on a 2500 µm2 sized square and compared the nuclear 
levels of both transcriptions factors in immunostained cells to the respective activity on a four 
times larger square harboring four cells (Fig. 3-2A). A quantitative analysis of ≥ 30 cells for 
each of the two patterns revealed that both MRTF-A and YAP exhibit significantly reduced 
nuclear levels upon the formation of cell-cell contacts (Fig. 3-2B).  
 
 
Figure 3-2 | Role of endothelial cell-cell contacts in regulating MRTF-A and YAP subcellular localization.  
(A) HUVEC were seeded onto the micropatterns depicted on the left and after 20 h co-stained for F-actin, MRTF-
A and YAP. Bars = 35 µm. (B) Nuclear levels of MRTF-A and YAP in terms of nuclear intensity divided by total 
cellular intensity were quantified in ≥ 30 cells for each of the two patterns in three independent experiments. Data 
is presented as box and whiskers (min to max) plot, significance determined by student t-test, p < 0.05. 
 
To further assess the importance of cell-cell contacts in regulating MRTF-A and YAP activity, 
we analyzed the contribution of VE-cadherin, a key component of endothelial adherens 
junctions, to this process. For the experiment shown in Fig. 3-3A, HUVEC were grown to 
confluency and subsequently treated with EGTA to disrupt existing Ca2+ dependent cell-cell 
junctions. Before re-addition of Ca2+, the cells were incubated with an antibody targeted against 
the extracellular domain of VE-cadherin (anti VE-CadECD), thereby inhibiting a reestablishment 
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of disrupted adherens junctions. As it is shown by the quantification depicted in Fig. 3-3B, 
preincubation with anti VE-CadECD clearly enhanced nuclear translocation of MRTF-A and YAP 
after re-addition of Ca2+ compared to untreated control cells. However, we observed different 
kinetics in the response of both transcription factors to restored Ca2+ levels in untreated control 
cells (Fig. 3-3B). This was particularly evident after 60 min, when MRTF-A was localized 
predominantly cytoplasmatic in the majority of control cells, while YAP was still localized in the 
nuclear compartment. 
In summary, these results suggest that endothelial cell-cell contacts in general, and VE-
cadherin containing junctions in particular, play a major role in regulating MRTF-A and YAP 
subcellular localization in endothelial cells. 
 
 
 
 
 
 
 
 
Figure 3-3 | VE-cadherins mediate the inhibitory effect of cell-cell contact formation on MRTF-A and YAP. 
(A) Confluent HUVEC were pre-treated with EGTA to disrupt VE-cadherin containing cell junctions (left panel). After 
EGTA removal and re-addition of Ca2+, cells were incubated with (+ anti VE-Cad) or without an antibody blocking 
the extracellular domain of VE-cadherin. Cells are stained for MRTF-A (top) or YAP (bottom). Bars = 35 µm. (B) 
Nuclear levels of MRTF-A and YAP were quantified as % nuclear intensity per field of view in ≥ 5 pictures per setting 
and analyzed in ≥ 50 cells after 30, 60 and 90 min. 
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3.1.3 MRTF-A and YAP activity correlates with the provided adhesive surface area 
 
Having studied the impact of cell-cell contacts on MRTF-A and YAP subcellular localization 
(3.1.2), we went on to analyze how an alteration of the provided adhesive surface area might 
affect the regulation of both transcription factors. For this purpose, a set of four different 
microadhesive squares covering a size range from 900 to 3600 µm2 was used. The activity of 
MRTF-A and YAP in terms of their relative nuclear intensities was analyzed in a minimum of 
30 cells for each of the squares described in Fig. 3-4A. Regarding the subcellular localization 
of MRTF-A, we found a significant correlation between the provided adhesive surface area 
and relative nuclear signal intensities of this protein (Fig. 3-4B). The same tendency was 
observed for YAP, though slightly less pronounced.  
 
 
Figure 3-4 | Influence of adhesive surface area on MRTF-A and YAP subcellular localization in HUVEC. (A) 
HUVEC were seeded onto square micropatterns of varying surface areas ranging from 900 to 3600 µm2. After 20 h, 
cells were stained for F-actin, MRTF-A and YAP. Bars = 30 µm. (B) Nuclear levels of both transcription factors in 
terms of nuclear intensity divided by total cellular intensity were quantified in ≥ 30 cells derived from three 
independent experiments and normalized to the respective compartment area. Data is presented as box and 
whiskers (min to max) plot, statistical significance was determined by ordinary one-way ANOVA followed by 
Dunnett’s multiple comparisons test. (C) Relative mRNA expression levels of prominent SRF and YAP / TAZ target 
genes were analyzed in HUVEC lysates collected from cells grown under normal 2D cell culture conditions and 
compared to cells grown on low-adhesive linear microtracks (3 µm line width). GAPDH was used as a housekeeper. 
Statistical significance was determined by student t-test, p < 0.05. 
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To test whether an alteration of adhesive properties would result in an adapted expression of 
MRTF-A and YAP target genes, quantitative real-time PCR on four known SRF-MRTF-A and 
Hippo-YAP / TAZ targets was performed (Fig. 3-4C). In detail, we compared mRNA levels of 
sparsely cultured HUVEC with infinite spreading area to the expression levels of cells cultured 
on low-adhesive, narrow microtracks, which had been previously described in our lab 76. 
Compared to the square patterns illustrated in Fig. 3-4A, which are sometimes occupied by 
multiple cells, the linear microtracks offer the advantage to collect lysates from a 
homogeneously low-adhesive cell population. In line with our findings for the nuclear levels of 
MRTF-A and YAP on differently sized squares, we found that mRNA levels were significantly 
reduced in cells grown on low-adhesive microtracks compared to cells in standard 2D cell 
culture (Fig. 3-4C). 
Taken together, our results demonstrate that the adhesive properties of the microenvironment 
influence MRTF-A and YAP subcellular localization and transcriptional activity in endothelial 
cells. We further showed that there is a correlation between the provided adhesive area and 
nuclear levels of both transcription factors. 
 
3.1.4 Influence of cell shape on nuclear levels of MRTF-A and YAP 
 
 
Figure 3-5 | Impact of cell shape variation on MRTF-A and YAP subcellular localization in HUVEC.                   
(A) HUVEC were seeded onto 2500 µm2 sized micropatterns of different geometries. After 20 h, cells were stained 
for F-actin, MRTF-A and YAP. Bars = 30 µm. (B) Nuclear levels of both transcription factors in terms of nuclear 
intensity divided by total cellular intensity were quantified in ≥ 30 cells in at least three independent experiments. 
Data is presented as box and whiskers (min to max) plot, statistical significance was determined by ordinary one-
way ANOVA followed by Dunnett’s multiple comparisons test. 
Sq
ua
re
Re
cta
ng
ula
r
Tri
an
gle
Cir
cle
0
10
20
30
40
50
%
 N
uc
lea
r I
nt
en
sit
y
n.s.
n.s.
n.s.
F-Actin / Nuclei MRTF-A YAP 
Sq
ua
re
 
Re
ct
an
gu
la
r 
Tr
ia
ng
le
 
Ci
rc
le
 
50 µm 
83
 µ
m
 
30 µm 
65 µm 
57 µm 
Sq
ua
re
Re
cta
ng
ula
r
Tri
an
gle
Cir
cle
0
10
20
30
40
50
%
 N
uc
lea
r I
nt
en
sit
y
n.s.
n.s.
n.s.
MRTF-A 
YAP 
A B 
3 Results I: Regulation of MRTF-A and YAP in angiogenesis 
  18 
During sprouting angiogenesis, endothelial tip cells adapt a distinct morphology, which is 
characterized by the presence of filopodia and a stretched cellular shape. To examine the 
impact of different cell shapes on subcellular localization of MRTF-A and YAP, we used a set 
of four 2500 µm2 sized microdomains with different geometrical shapes (Fig. 3-5A). We found 
that nuclear levels of MRTF-A and YAP on either of these microstructures varied in a small 
range of 20 – 30% (Fig. 3-5A). However, none of the applied shapes induced a significant 
difference in MRTF-A and YAP subcellular localization compared to the control square pattern. 
We therefore conclude that, unlike the presence of cell-cell contacts or the provided adhesive 
surface area, cell shape plays a minor role in regulating the activity of MRTF-A and YAP in 
endothelial cells. 
 
3.2 MRTF-A and YAP underlie different regulatory kinetics in HUVEC 
3.2.1 MRTF-A translocates during cell migration on dumbbell-shaped micropatterns 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6 | Translocation dynamics of MRTF-A and YAP during migration on dumbbell-shaped 
micropatterns. Subconfluent HUVEC were transiently transfected with MRTF-A-GFP or hYAP1-GFP harboring 
expression vectors and after 24 h seeded either onto a micropattern composed of interconnected squares (A) or 
onto unconnected control patterns (B). Cell migration was subsequently analyzed by time-lapse imaging over the 
indicated time spans. Bars = 30 µm. (C) Top: Pattern geometries of the experiments depicted in (A) and (B). Bottom: 
Absolute and relative translocation events of MRTF-A and YAP. Relative numbers are normalized to the total 
number of shape transitions. 
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The results described in section 3.1 suggest that MRTF-A and YAP react very similar to static 
microenvironmental conditions. However, this does not imply that the activity of these 
transcription factors is necessarily coupled at any time point in a more dynamic system. To 
analyze the activation kinetics of MRTF-A and YAP in response to a changing 
microenvironment, we used a dumbbell-shaped micropattern composed of interconnected 
squares (Fig. 3-6A). Time-lapse imaging of MRTF-A-GFP and hYAP1-GFP expressing 
HUVEC revealed that MRTF-A frequently translocated between the nuclear and the 
cytoplasmatic compartment during cell migration between adjacent squares. More precisely, 
the transition phase between lines and squares served as a stimulus to nuclear redistribution 
of MRTF-A in our cells, while YAP remained mostly cytoplasmatic in the same experiment (Fig. 
3-6C).  To exclude the possibility that the frequent shuttling of MRTF-A occurred as a random 
event, e.g. due to different expression levels of MRTF-A-GFP and hYAP1-GFP, we also 
imaged cells on unconnected control squares (Fig. 3-6B). Under these circumstances, we did 
not observe translocation of MRTF-A, proving that the described translocation on the 
dumbbell-shaped structures was indeed induced by the changes in pattern geometry. 
In summary, our results suggest that MTRF-A reacts more sensitive to dynamic changes of 
the cellular microenvironment than YAP. 
 
3.2.2 Translocation kinetics of MRTF-A and YAP in response to fluid shear stress 
 
Among the numerous mechanical challenges, which require an adaptation of cell morphology 
during angiogenesis, shear stress is probably the most important force encountered by the 
endothelium 79. To verify our assumption that MRTF-A reacts faster or more sensitive 
(ref. 3.2.1) to a given extracellular stimulus than YAP, we transfected endothelial cells with 
MRTF-A-GFP and hYAP1-GFP carrying constructs and analyzed the subcellular localization 
of both proteins under flow conditions (Fig. 3-7A). For this purpose, transfected cells were 
subjected to a constant shear stress of approximately 15 dyn / cm2 and nuclear intensity traces 
were recorded over a time period of several hours. The results depicted in Fig. 3-7B 
demonstrate that while MRTF-A had completely translocated to the nucleus after 2 hours, 
nuclear redistribution of YAP was delayed until 5 hours after the onset of flow. 
To confirm our results for endogenous MRTF-A and YAP, we performed immunostainings in 
fixed cells after 1 and 16 hours of flow cultivation (Fig. 3-7C). Similar to our results for the 
transfected cells, we found that MRTF-A translocated significantly faster than YAP in these 
experiments. Moreover, MRTF-A activity was readily reduced after 16 hours, whereas YAP 
was still localized in the nuclear compartment at this time point. 
Finally, we addressed the question whether the above-described differential regulatory kinetics 
would result in time-dependent variations of MRTF-A and YAP target gene expression after an 
3 Results I: Regulation of MRTF-A and YAP in angiogenesis 
  20 
activating stimulus. In collaboration with the group of Prof. Wolfgang Enard (Department 
Biology II, LMU Munich, Germany), we generated transcriptome data (RNA-seq) of spreading 
endothelial cells at early (2 h) and late (4 h) time points and compared the number of 
upregulated (log2-fold change > 2) MRTF-A and YAP target genes based on two recently 
published lists for the CArG-Box 80 and TEAD 81 promoters (Fig. 3-7D). We found that, in 
support of our imaging data, the number of upregulated SRF target genes was strongly 
reduced after 4 hours, whereas YAP - and also shared YAP / MRTF-A target genes - showed 
a more consistent expression over time.  
 
 
 
 
Figure 3-7 | (A) MRTF-A and YAP exhibit different activation kinetics in response to mechanical stress. 
MRTF-A-GFP or hYAP1-GFP expressing HUVEC were subjected to laminar shear stress (15 dyn / cm2) and time-
lapse imaged in perfusion assay chambers over the indicated time spans. (B) Representative time traces of MRTF-
A and YAP nuclear intensities after the onset of flow. (C) Representative IF stainings (left) and nuclear intensity 
quantification (right) of endogenous MRTF-A and YAP levels after 1 and 16 h of cultivation under the conditions 
described in (A). Bars = 30 µm. (D) Transcriptome heatmap showing upregulated (log2-fold change > 2) MRTF, 
TCF and YAP-driven target genes in spreading endothelial cells; analyzed data refers to confluent control cells. 
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3.3 Regulation of MRTF-A and YAP in angiogenic model systems 
3.3.1 Spatiotemporal differences in MRTF-A and YAP activity during tube formation 
 
 
Figure 3-8 | Expression pattern and nuclear levels of MRTF-A and YAP during endothelial tube formation. 
(A) Endothelial cells (11 x 103) were seeded onto thin layers of MatrigelTM and incubated for indicated time spans. 
Tubular structures were stained for MRTF-A, YAP and DNA. (B) Subcellular localization of MRTF-A and YAP was 
determined via intensity quantification in Hoechst positive areas in relation to total signal intensity. Bars representing 
mean + SEM from three independent experiments, statistical significance was determined by unpaired student t-
test, p ≤ 0.05. (C) Pearson coefficients (r above threshold) were calculated to express the correlation between YAP 
and MRTF-A intensity distribution for central and sprouting regions at 2 h, 6 h and 20 h. Representative examples 
for each of the two regions are highlighted by white boxes in (A).  
 
Having shown that MRTF-A and YAP share microenvironmental triggers, but underlie different 
kinetics in single endothelial cells, we went on to test whether the regulatory model depicted 
in Fig. 2-8 could be transferred to an angiogenic model system in vitro. Therefore, we 
performed tube formation assays on top of thin MatrigelTM layers and co-stained the resulting 
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threshold were calculated as a measure of correlation between MRTF-A and YAP at different 
positions within the network.  
As it is demonstrated by the representative pictures in Fig. 3-8A, MRTF-A was higher 
expressed in mechanically strained tubular regions compared to inner areas of the network. In 
addition to the expression, also nuclear levels of MRTF-A were significantly higher in tubular 
regions, as it is shown by the quantification in Fig. 3-8B. For YAP, a similar, though not 
significant tendency was observed.  
Apart from a location-dependent but otherwise congruent activity of MRTF-A and YAP at a 
given time point, we observed time-dependent variations in the correlation between both 
transcription factors. In detail, the correlation was highest in the mature network (20 h) with a 
Pearson coefficient of 0.73 compared to 0.55 and 0.33 at earlier time points (Fig. 3-8C). In line 
with our previous data (ref. sections 2.1 and 2.2.), this indicates that, although the principal 
response of MRTF-A and YAP to a given microenvironmental stimulus is similar, there are 
kinetic differences regarding their activation. 
 
3.3.2 Retinal whole-mount stainings: expression patterns of MRTF-A and YAP in vivo 
 
 
Figure 3-9 | Retinal whole-mount stainings of wild-type C57BL/6 mice at postnatal day 6 (P6). Retinal 
vasculature is visualized by IB4 labelling and samples are co-stained for MRTF-A and YAP. Representative images 
for the sprouting front and the inner network are shown, bars = 30 µm. 
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To examine the expression pattern of MRTF-A and YAP in vivo, we performed whole-mount 
stainings of C57BL/6 mouse retinas at postnatal day 6 (Fig. 3-9). We found that MRTF-A was 
highly expressed in sprouting regions of the developing retinal vasculature (upper panel). This 
is in line with a previous report of Franco et al. 34. Remarkably, the expression of MRTF-A was 
clearly reduced in already matured inner areas of the retina (bottom panel). Regarding the 
expression of YAP, we observed an adverse behavior, which becomes particularly evident 
when directly comparing both channels (see merged pictures in Fig. 3-9). 
Taken together, the results presented in section 3.3 show that the activity of MRTF-A and YAP 
is regulated in a time- and location-dependent manner during tubular network formation 
in vitro. In line with this, we observed differential expression patterns of MRTF-A and YAP in 
the developing retinal vasculature in vivo.  
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4 Results II: Targeting of endothelial mechanosensing with actin 
binding compounds 
 
4.1 Actin binding compounds regulate endothelial gene transcription 
4.1.1 Transcriptional profiling of actin binding compounds 
 
As a foundation to analyzing the effects of different actin binding compounds on transcriptional 
regulation in general and mechanosensitive signaling pathways in particular, we addressed 
the question whether moderate concentrations of these compounds would be able to 
significantly alter gene transcription in endothelial cells. For this purpose, a transcriptomic 
approach with four different actin binding compounds was performed in collaboration with the 
group of Prof. Wolfgang Enard (Department Biology II, LMU Munich, Germany). Fig. 4-1 
summarizes the data obtained for the actin polymerizing compound Miuraenamide A, which 
was kindly provided by the lab of Prof. Uli Kazmaier 66 (Institute for Organic Chemistry, 
Saarland University, Saarbrücken, Germany). As indicated by the topGO enrichment analysis 
shown in Fig. 4-1B, most of the genes that were significantly up- or downregulated after 
stimulation with Miuraenamide A could be allocated to cytoskeleton-associated processes 
such as lamellipodium formation or actin filament organization. Notably, although the 
transcriptomic analysis yielded 594 genes that where regulated in response to Miuraenamide 
A versus untreated control cells, there were only marginal differences between 
Miuraenamide A and the commercially available actin polymerizing drug Jasplakinolide (Fig. 4-
1D). We therefore decided to perform all further experiments with only Miuraenamide A as an 
exemplary substance representing the class of actin polymerizing compounds. 
Since the compound-induced polymerization of actin strongly affected gene regulation in our 
cells, we assumed that an increased depolymerization of actin might have similar effects. 
Therefore, we tested the influence of the commercially available actin depolymerizing 
compound Latrunculin B on gene transcription in HUVEC (Fig. 4-2). As shown by the Volcano 
plot of gene expression in Fig. 4-2B, 312 significantly regulated genes were detected in 
response to stimulation with 250 nM Latrunculin B. The subsequent topGO gene enrichment 
analysis showed that, in contrast to treatment with actin polymerizing compounds (Fig. 4-1), 
most of the regulated genes were assigned to cellular processes involved in angiogenesis and 
the response to hypoxia (Fig. 4-2C). In addition to Latrunculin B, we also tested the novel 
myxobacterial compound Chivosazole A, which was isolated from Sorangium cellulosum in 
the lab of Prof. Rolf Müller (Helmholtz Institute of Pharmaceutical Research Saarland, 
Saarbrücken, Germany) 70,82. In line with the previously tested actin polymerizers, we did not 
see a substantial difference when comparing the two depolymerizing compounds. 
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In sum, our data suggests that moderate concentrations of actin binding compounds are able 
to interfere with transcriptional regulation in endothelial cells. Moreover, although there were 
significant differences regarding the respective gene sets influenced by polymerizing versus 
depolymerizing compounds, class-internal differences were only marginal in our experiments.  
 
 
Figure 4-1 | Influence of actin polymerizing compound Miuraenamide A on endothelial gene transcription. 
(A) Top: Molecular structure of Miuraenamide A. Bottom: Representative F-actin staining in HUVEC after 4 h 
stimulation with 50 nM Miuraenamide A. (B) Volcano plot of differential gene expression in cells stimulated with 
60 nM Miuraenamide A versus control. The colored points indicate significantly differentially expressed genes 
(FDR < 0.1). (C) Enriched and filtered topGO categories for stimulation with Miuraenamide A versus control. (D) 
Top: Molecular structure of Jasplakinolide. Bottom: Volcano plot of differential gene expression in cells stimulated 
with 60 nM Miuraenamide A versus 120 nM Jasplakinolide. (E) Enriched and filtered topGO categories for 
stimulation with 60 nM Miuraenamide A versus 120 nM Jasplakinolide. Asterisks show the level of significance of 
Fisher’s exact test for the enrichment of the particular term. p-values: * <0.01; ** <0.001; *** <0.0001. 
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Figure 4-2 | Influence of actin depolymerizing compound Latrunculin B on endothelial gene transcription. 
(A) Top: Molecular structure of Latrunculin B. Bottom: Representative F-actin staining in HUVEC after 4 h 
stimulation with 250 nM Latrunculin B. (B) Volcano plot of differential gene expression in cells stimulated with 250 
nM Latrunculin B versus control. The colored points indicate significantly differentially expressed genes (FDR < 
0.1). (C) Enriched and filtered topGO categories for stimulation with Latrunculin B versus control. (D) Top: Molecular 
structure of Chivosazole A. Bottom: Volcano plot of differential gene expression in cells stimulated with 250 nM 
Latrunculin B versus 20 nM Chivosazole. (E) Enriched and filtered topGO categories for stimulation with 250 nM 
Latrunculin B versus 20 nM Chivosazole. Asterisks show the level of significance of Fisher’s exact test for the 
enrichment of the particular term. p-values: * <0.01; ** <0.001; *** <0.0001. 
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4.1.2 Influence on chromatin organization and epigenetic modification 
 
Apart from the regulation of specific mechanosensitive transcription factors, actin is known to 
regulate gene expression via several other mechanisms and target structures such as 
polymerase function, chromatin organization or histone modification. Therefore, the effects of 
actin binding compounds on endothelial gene expression, as they are described in section 
3.1.1, could be at least partially caused by an interference of these compounds with one or 
more of the aforementioned aspects. 
To test whether actin binding compounds affect chromatin organization, we stimulated HUVEC 
with either Miuraenamide A or Latrunculin B and visualized the respective chromatin structures 
using the DNA intercalating dye Hoechst 33342 (Fig. 4-3). The intensity scans and 
representative images shown in Fig. 4-3A1 illustrate that stimulation with either of the two 
compounds drastically affected chromatin architecture and nuclear shape. This was supported 
by an analysis of the cell percentage exhibiting an altered chromatin structure and the 
calculation of nuclear perimeter to area ratios in > 30 cells (Fig. 4-3A2). 
 
 
Figure 4-3 | Effects of Miuraenamide A and Latrunculin B on nuclear structure, chromatin organization and 
histone modification. (A1) Hoechst staining of HUVEC nuclei after stimulation with either Miuraenamide A or 
Latrunculin B. Positions of the intensity scans depicted on the right are indicated by red lines. (A2) Percentage of 
cells with a condensed chromatin phenotype (left) and nuclear perimeter to area ratio (right) after stimulation as in 
(A1). (B) Chromatin accessibility was determined by DNAse I digestion and subsequent Hoechst 33342 staining of 
HUVEC nuclei. (C) Representative Western blot and quantified protein levels of methylated and acetylated histone 
forms after stimulation with either Miuraenamide A or Latrunculin B. Statistical significance in all shown experiments 
was determined by ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test. 
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To assess the impact of Miuraenamide A and Latrunculin B on chromatin condensation in more 
detail, we performed a previously described DNAse I digestion assay 58. As illustrated by the 
quantification of undigested and therefore inaccessible chromatin depicted in Fig. 4-3C, both 
Miuraenamide A and Latrunculin B significantly increased the fraction of condensed chromatin. 
We subsequently analyzed the effect of actin binding compounds on histone modification 
(Fig. 4-3C). Western blot analysis of acetylated and methylated histone forms after stimulation 
with either Miuraenamide A or Latrunculin B revealed that, apart from a minor decrease in 
histone acetylation, neither of the compounds significantly affected epigenetic histone 
modification. 
 
4.1.3 Influence on polymerase function and rRNA synthesis 
 
 
Figure 4-4 | Effects of Miuraenamide A and Latrunculin B on transcriptional capability and rRNA synthesis. 
(A) Representative images (top) and quantitative analysis (bottom) of nuclear run-on assays performed after pre-
stimulation with Miuraenamide A or Latrunculin B. Actinomycin D = negative control. Cells were counted as positive 
upon the presence of visible nucleolar 5-FU foci. (B) Duolink proximity ligation assay showing the interaction 
between ß-actin and DNA Polymerase I in Miuraenamide A and Latrunculin B-treated cells. (C) Relative 18S rRNA 
expression levels after stimulation with Miuraenamide A or Latrunculin B. Statistical significance in all experiments 
was determined by ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test. 
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fluorouracil (5-FU) into nascent RNA transcripts 44. The resulting 5-FU containing transcripts 
can later be visualized and quantified as a measure of ongoing transcriptional activity. As 
shown in Fig. 4-4A, pre-stimulation with 7.5 µg/ml actinomycin D, a DNA intercalating drug, 
completely abrogated the incorporation of 5-FU in our cells. However, we did not observe a 
significant difference in the relative amount of nuclear 5-FU foci after 4 and 8 hours of 
stimulation with either Miuraenamide A or Latrunculin B. 
To verify our assumption that moderate doses of Miuraenamide A and Latrunculin B are unable 
to disturb the interaction between DNA polymerases and nuclear ß-actin, a Duolink proximity 
ligation assay (PLA) targeting DNA polymerase I and ß-actin was performed. As shown by the 
representative images and the quantitative analysis in Fig. 4-4B, we could indeed detect an 
interaction between both proteins in the nuclear compartment. In line with our nuclear run on 
assay data, there was no significant change in the number of amplified PLA signals after 
stimulation with Miuraenamide A or Latrunculin B. This was further supported by the 
quantitative real-time PCR analysis of 18S rRNA synthesis, which is transcribed by RNA 
polymerase I in the nucleoli (Fig. 4-4C). 
In sum, our data states that RNA polymerase function and therefore cellular transcriptional 
capability is unaffected by the stimulation with actin binding compounds Miuraenamide A or 
Latrunculin B.  
 
4.2 Effects of actin binding compounds on nuclear actin 
4.2.1 Visualization of nuclear actin with different actin probes 
 
Due to its high cytoplasmatic abundancy and the related fluorescence intensities in this 
compartment, nuclear actin is hard to visualize in both living and fixed cells. To improve the 
detection intensity of polymerized nuclear actin, specialized protocols for phalloidin stainings 
and nuclear actin targeting probes have been developed in recent years 42,43. 
In order to investigate the influence of Miuraenamide A and Latrunculin B on the structure of 
nuclear actin, we used a phalloidin staining protocol that is based on glutaraldehyde fixation 
and the subsequent use of cytoskeleton stabilizing buffers (CSB, see section 6.2.3.2). As 
shown in Fig. 4-5A, polymerized nuclear actin was not present in the nuclei of untreated control 
NIH3T3 cells. Of note, we were able to visualize the transient formation of nuclear actin fibers 
in starved NIH3T3 cells after serum stimulation, as it had previously been reported by Baarlink 
et al. 46. Nevertheless, we could not detect any resembling structures after stimulation with 
actin binding compounds, regardless of whether the cells were treated long term or short term 
(Fig. 4-5A). 
F-actin binding by phalloidin has been reported to be competitive with the actin polymerizing 
substance Jasplakinolide 83. Since this could also be the case for the structurally related 
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compound Miuraenamide A, we switched to a second visualization approach based on the 
expression of actin-binding antibody fragments fused to a nuclear localization sequence 
(nuclear actin chromobody, nAC, Fig. 3-5B). The major advantage of this probe is an improved 
signal to noise ratio compared to other actin binding substances that are distributed throughout 
the cytoplasm. Time-lapse imaging of nAC expressing cells - under the same stimulation 
conditions as described for the experiments with phalloidin - showed that Miuraenamide A and 
Latrunculin B led to increased signal intensities in the nucleolar compartment in a small fraction 
of cells (5 - 10%, left panel in Fig. 4-5B). However, since this could not be considered a general 
phenomenon, we concluded that neither of the two applied visualization techniques could 
prove a formation of polymerized or aggregated actin structures in response to stimulation with 
actin binding compounds in our cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4-5 | Visualization of nuclear actin in NIH3T3 fibroblasts. (A) Phalloidin stainings of nuclear actin in 
NIH3T3 fibroblasts. FCS stimulation of starved cells was used as a positive control for induction of nuclear actin 
polymerization. (B) Representative images (left) and time lapse imaging series (right) of nAC-GFP expressing 
NIH3T3 fibroblasts after stimulation with FCS or 50 nM Miuraenamide A. All bars = 10 µm. 
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4.2.2 Miuraenamide A and Latrunculin B bidirectionally shift nuclear actin levels 
 
 
Figure 4-6 | Miuraenamide A and Latrunculin B adversatively shift the concentration of nuclear actin.           
EGFP-ß-actin expressing HUVEC were stimulated with Miuraenamide A (A1) or Latrunculin B (B1) and the 
dynamics of nuclear actin were analyzed by single-points FCS measurements. The representative confocal images 
and autocorrelation curves depicted in panels A1 and B1 were acquired 0, 5, 15 and 25 minutes after stimulation. 
(A2) and (B2): Nuclear concentration and diffusion coefficients were determined in > 40 cells for each setting. Bars 
representing mean + SEM, statistical significance was determined by ordinary one-way ANOVA followed by 
Dunnett’s multiple comparisons test. (D) Time lapse imaging series of actin-YFP-NLS expressing HUVEC after 
stimulation with Miuraenamide A or Latrunculin B.  
 
The results of section 4.2 thus far suggested that nanomolar concentrations of our two 
reference substances Miuraenamide A and Latrunculin B have no significant impact on 
intranuclear actin. However, the lack of visible, large-scale filaments or even aggregates does 
A1 
B1 
M
iu
ra
en
am
id
e 
A 
0   5 15 25 t [min] 
La
tru
nc
ul
in
 B
 
0   5 15 25 t [min] 
A2 
B2 
Ac
tin
-Y
FP
-N
LS
 
C 
0 5 15 25
0
10
20
30
40
time [min]
D 
[µ
m
2 /s
]
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
***
0 5 15 25
0
10
20
30
40
time [min]
D 
[µ
m
2 /s
]
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
***
**
4 Results II: Targeting of endothelial mechanosensing with actin binding compounds 
  32 
not exclude the possibility that shorter actin oligomers are formed upon stimulation with either 
of these compounds. Moreover, a disturbance of the cytoplasmatic actin pool might indirectly 
affect the number of actin monomers available for nuclear import. 
To investigate the relevance of the above-mentioned aspects in endothelial cells, we 
performed fluorescence correlation spectroscopy (FCS) measurements with ß-actin-GFP 
expressing HUVEC (Fig. 4-6A1 and 4-6B1). Time-resolved analysis of nuclear ß-actin-GFP 
concentration and diffusion rate in response to stimulation with Miuraenamide A revealed that, 
although there was no change in the diffusion coefficient and therefore aggregation state of 
intranuclear actin, the concentration significantly decreased over time (Fig. 4-6A2). 
Remarkably, the depolymerizing compound Latrunculin B caused an increase in the 
concentration of nuclear ß-actin-GFP under similar conditions (Fig. 4-6B2).  
Since a considerable fraction of nuclear actin could either be incorporated into larger protein 
complexes or form polymers, we also applied a two-component fitting model 84,85 and obtained 
similar results for both diffusion coefficients (Fig. S1). 
To confirm our assumption that actin binding compounds would rather affect the concentration 
of nuclear actin instead of its polymerization state, we transiently transfected endothelial cells 
with a fluorescence labeled ß-actin-NLS construct, thereby increasing the steady state 
concentration of nuclear actin. Time lapse imaging of these cells after stimulation with either 
of the two compounds showed that, in line with our hypothesis, Miuraenamide A and 
Latrunculin B led to a decrease of nuclear signal intensity or to an increase, respectively 
(Fig. 4-6C). 
 
4.2.3 Influence of actin binding compounds on intranuclear polymerization state 
 
The FCS data presented in Fig. 4-6 allowed us to gain insight into the response of nuclear 
actin to treatment with Miuraenamide A or Latrunculin B. Unfortunately, due to the high 
concentration of cytoplasmatic actin, this compartment could not be measured with standard 
FCS techniques. In order to obtain comparative data for the polymerization state of actin in 
both the nuclear and the cytoplasmatic compartment, we switched to a novel approach termed 
raster image correlation spectroscopy (RICS 86-88, Fig. 4-7A). These experiments were 
performed in collaboration with the group of Prof. Don C. Lamb (Department of Chemistry, 
Center for Integrated Protein Sciences, Munich, Germany). The major advantage of RICS is 
that a two-directional scanning process allows the reliable detection of a wide range of 
concentrations and diffusion coefficients, thereby enabling us to simultaneously detect 
aggregation in both compartments. Moreover, the larger observation area allows to exclude 
any disturbing structures like vesicles or larger fibers from the analysis (arbitrary region 
RICS 89), which is particularly important for cytoplasmatic measurements.  
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Figure 4-7 | RICS analysis of actin aggregation in response to actin binding compounds. (A) Schematic 
explanation of RICS data acquisition. (1) Images are acquired by a raster scan pattern providing diffusion 
information of particles moving on three different time scales. (2) The image series is correlated with spatial 
increments upon the horizontal and vertical axes, thus providing diffusion information on three different timescales. 
(3) By fitting the correlation values from (2), the information on particles and diffusion is extracted. (B) 
Representative images of EGFP- and mCherry-ß-actin expressing HUVEC before (0 min) and 30 min after 
stimulation with 100 nM Miuraenamide A or 250 nM Latrunculin B. (C + D) Experimental ccRICS data obtained for 
the cytoplasmic (C1 + D1) and nuclear (C2 + D2) compartments upon stimulation with Miuraenamide A (C1 + C2) 
and Latrunculin B (D1 + D2). Left: mean SCCFs in 3D, color coded for the correlation values: SCCF before (top) 
and 20 min after (bottom) compound addition. Right: two-component fits of the data before (top) and 20 min after 
(bottom) compound addition. Fits are color coded according to the value of the goodness-of-fit weighted residuals 
parameter (W. Res.), where gray illustrates a good fit and red–blue indicates regions where the residuals deviate 
by > 5 σ. (E) Time course of relative cross-correlation between EGFP- and mCherry-ß-actin in the nuclear versus 
cytoplasmatic compartment in response to Miuraenamide A (left) and Latrunculin B (right). 
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To increase the sensitivity of standard one-component RICS analysis, we analyzed cross-
correlation of two fluorescently labelled ß-actin derivatives, namely mCherry- and GFP-actin, 
over a time period of up to 45 minutes after stimulation with either Miuraenamide A or 
Latrunculin B (Fig. 4-7B). As demonstrated by the representative 2D Gaussian plots depicted 
in Fig. 4-7C, Miuraenamide A caused a drastic increase in relative cross-correlation throughout 
the cytoplasm, while the nuclear compartment remained unaffected in the same cells. The 
mean cross-correlation over time within the nuclear versus the cytoplasmatic compartment is 
plotted in Fig. 4-7E. A similar tendency was observed for the autocorrelation of the EGFP and 
mCherry constructs alone (Fig. S2 + S3). 
Notably, an excessive concentration of Miuraenamide (2 µM) readily induced nuclear actin 
aggregates in actin-YFP-NLS expressing cells (Fig. 4-8), further supporting our hypothesis that 
moderate doses of actin polymerizing compounds are not able to reach the nucleus in a 
concentration that could induce aggregation. 
 
 
 
 
 
 
 
 
Figure 4-8 | High concentrations of Miuraenamide A induce nuclear actin aggregation in HUVEC.               
Time-lapse imaging series of YFP-NLS-actin expressing HUVEC after stimulation with 2 µM Miuraenamide A. The 
nucleus is delineated with dashed white lines. 
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4.3 Effects of actin binding compounds on mechanosensitive pathways 
4.3.1 Influence of Miuraenamide A on MRTF-A and YAP subcellular localization 
 
 
Figure 4-9 | Fig. 5 Miuraenamide A activates MRTF-A but not YAP. (A) Live cell imaging sequence of MRTF-A-
GFP and hYAP1-mCherry co-expressing endothelial cell. The cell was imaged over a time span of 90 min after 
stimulation with 50 nM Miuraenamide A at t = 15 min. Bar = 30 µm. (B1) Immunostaining of MRTF-A and YAP in 
confluent HUVEC after 5 h stimulation with either 50 nM Miuraenamide A, 250 nM Latrunculin B or 0.5 U thrombin. 
(B2) Quantification of nuclear MRTF-A and YAP levels for the experiment shown in (B1). Nuclear protein levels are 
expressed as nuclear signal intensity divided by total cellular intensity. (C) Dual luciferase reporter gene assays for 
SRF response element (C1) and YAP / TAZ promotor (C2). Luciferase reporter activity is expressed as firefly RLU 
normalized to the constitutive renilla control construct.  
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Miuraenamide A, since actin polymerization is commonly accepted as an activating stimulus 
for MRTF-A and YAP-dependent gene transcription (ref. sections 2.2.2, 2.2.3).  
To simultaneously analyze the subcellular localization of MRTF-A and YAP in live cells, we co-
transfected HUVEC with MRTF-A-GFP and hYAP1-mCherry carrying constructs (Fig. 4-9A). 
Upon stimulation with 50 nM Miuraenamide A, we observed a rapid and complete nuclear 
translocation of MRTF-A. In contrast, subcellular localization of YAP was not affected by 
Miuraenamide A, even at late time points. Since the translocation kinetics of both transcription 
factors could be influenced by overexpression and / or the GFP- and mCherry tags, we also 
analyzed the subcellular localization of endogenous MRTF-A and YAP via immunostaining of 
fixed cells (Fig. 4-9B). Similar to our observation in live cells, we found that Miuraenamide A 
triggered the nuclear translocation of MRTF-A, but not YAP in our cells. Moreover, we found 
that, while the Latrunculin B had no significant effect on the localization of either transcription 
factor, the protease-activated receptor (PAR) ligand thrombin, a strong activator of Rho 
GTPase-induced actin polymerization, activated both MRTF-A and YAP.  
The different effects of Miuraenamide A, Latrunculin B and thrombin on MRTF-A and YAP 
activity could be further confirmed in dual luciferase reporter gene assays targeting the MRTF-
A-binding serum response element (SRE) and the YAP-binding TEA domain (Fig. 4-9C). 
In summary, our data shows that Miuraenamide A strongly activates the mechanosensitive 
transcription factor MRTF-A, while this compound has a minor effect on YAP. However, the 
actin polymerizing PAR ligand thrombin does not exhibit the same selectivity, indicating a more 
complex role of actin polymerization in the regulation of this protein.  
 
4.3.2 Promotor activation and MRTF-A / YAP target gene expression 
 
 
 
Figure 4-10 | Regulated SRF and YAP / TAZ target genes in response to stimulation with Miuraenamide A, 
Latrunculin B and thrombin. (A) Number of significantly up- and downregulated known SRF and YAP / TAZ target 
genes in response to stimulation with Miuraenamide A and Latrunculin B. (B) Volcano plot of gene expression and 
number of significantly up- and downregulated known SRF and YAP / TAZ target genes in response to stimulation 
with 0.5 U thrombin. The colored points indicate significantly differentially expressed genes (FDR < 0.1). 
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Our results at this stage pointed to the direction that Miuraenamide A activates the MRTF-A-
SRF signaling axis, but on the other hand has only marginal influence on the transcriptional 
coactivator YAP. To verify this hypothesis on a transcriptional level, we went back to the 
transcriptomic approach introduced in section 4.1 and searched the data set for significantly 
up- and downregulated MRTF-A and YAP / TAZ target genes 80,81. We found that, in line with 
our data on subcellular localization and SRE promotor activity, Miuraenamide A upregulated 
90 out of 99 detected MRTF-A target genes (Fig. 4-10A). On the other hand, only 13 out of 31 
YAP / TAZ targets were positively regulated by this compound, thus supporting our 
assumption that Miuraenamide A is far more efficient in activating MRTF-A compared to 
YAP / TAZ. In line with our data from section 4.3.1, we moreover found that the majority of 
MRTF-A and YAP / TAZ target genes was downregulated by the depolymerizing compound 
Latrunculin B (Fig. 4-10A). 
Apart from Miuraenamide A and Latrunculin B, we also generated transcriptome data for the 
Rho GTPase activator thrombin and found that, in good agreement with the data described in 
section 4.1, both MRTF-A (170 out of 201) and YAP / TAZ (43 out of 72) target genes were 
predominantly upregulated by this substance (Fig. 4-10B and Fig. S4). Therefore, our 
transcriptomic data underscores the finding that YAP is differently affected by actin 
polymerization induced by Miuraenamide A compared to the physiological PAR ligand 
thrombin. 
 
4.3.3 Role of AMOTp130 in linking F-actin levels to YAP activity 
 
The actin-dependent regulation of YAP has been a subject of ongoing debate over the last 
years 90-92. Although the protein family of angiomotins (AMOT), in particular its isoform 
AMOTp130, has been suggested to provide the regulatory link between actin polymerization 
state and subcellular localization of YAP, it is yet unclear whether the canonical Hippo kinase 
cascade is involved in this process.  
In order to investigate the mechanism by which cytoskeletal changes are translated into an 
adapted YAP activity profile, we analyzed the protein levels of phosphorylated YAP (pYAP) 
after stimulation with Miuraenamide A, Latrunculin B and thrombin (Fig. 4-11A). We found that 
while Latrunculin B led to a slight but significant increase of pYAP levels, neither 
Miuraenamide A nor thrombin affected the phosphorylation state of YAP. Since thrombin-
induced actin polymerization readily triggered YAP nuclear translocation and subsequent 
target gene expression (4.3.1 and 4.3.2), we concluded that the canonical Hippo pathway 
could not be the key mediator of this response. Therefore, we next assessed the role of 
AMOTp130 in actin-dependent activation of YAP. Overexpression of HA-tagged AMOTp130 
in HUVEC revealed that the nuclear translocation of YAP upon stimulation with thrombin was 
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completely abrogated by AMOTp130 (compare arrows for transfected versus non-transfected 
cells in Fig. 4-11B). Importantly, stimulation with Miuraenamide A had no effect on YAP 
subcellular localization, regardless of AMOTp130 expression levels.  
 
 
 
Figure 4-11 | Fig. 6 Miuraenamide A-induced actin polymerization fails to disrupt the interaction between 
AMOTp130 and YAP. (A) Western blot analysis (A1) and quantified protein levels (A2) of pYAP levels normalized 
to total YAP in cells treated with 50 nM Miuranamide A, 250 nM Latrunculin B or 0.5 U thrombin. (B) HUVEC were 
transiently transfected with HA-AMOTp130 carrying constructs and after 2 h stimulation with either 0.5 U thrombin 
or 100 nM Miuraenamide co-stained for F-actin, YAP and the overexpressed variant of AMOTp130. Bars = 30 µm. 
(C) HA-AMOTp130-expressing HUVEC were grown to confluency and stimulated as described in (B). After 
immunoprecipitation of endogenous YAP, bound AMOTp130 was detected via SDS-PAGE (C1, LC = loading 
control). (C2): Quantification of AMOTp130 levels normalized to total YAP, data derived from three independent 
experiments. Statistical significance in all experiments was determined using ordinary one-way ANOVA followed 
by Dunnett’s multiple comparisons test.  
 
To further investigate the role of AMOTp130 as a potential differentiator between 
Miuraenamide A- and thrombin-induced actin polymerization, Co-IP experiments targeting the 
interaction between YAP and AMOTp130 were performed (Fig. 4-11C). While we could indeed 
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detect an interaction between both proteins in untreated control cells, AMOTp130 was 
completely absent in the samples stimulated with thrombin. However, stimulation with 
Miuraenamide A only marginally weakened the interaction between YAP and AMOTp130 
(Fig. 4-11C2). 
In sum, our results confirm the role of AMOTp130 as a key mediator of actin-dependent YAP 
activation. Moreover, we found evidence that the regulatory crosstalk between AMOTp130, F-
actin and YAP is the factor that determines the lacking YAP activation by Miuraenamide A. 
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5 Discussion 
 
5.1 MRTF and YAP: the unequal twins 
5.1.1 MRTF and YAP share microenvironmental triggers 
 
The sprouting of blood vessels from an existing vascular network involves the spatiotemporally 
coordinated degradation of the surrounding extracellular matrix followed by an invasion into it. 
This process requires a careful sensing and subsequent adaptation of endothelial cells to 
changing biophysical properties 79,93. Thus far, the majority of work on endothelial 
mechanosensing has focused on vascular remodeling processes and altered redox signaling 
in response to fluid shear stress 79,94,95. However, current knowledge on the physiological 
regulation and functional behavior of mechanosensitive signaling pathways in the context of 
angiogenesis is limited. To date, it is only known that both MRTF-SRF and Hippo-YAP / TAZ 
are mandatory for vascular development 33,34,37,96. In particular, the question of whether these 
two signaling pathways are completely redundant backup systems, or at least partially 
collaborating 97,98, remained open.  
By varying the cell number on differently sized micro-adhesive squares, we observed that the 
loss of endothelial cell-cell contacts, a hallmark event in angiogenesis, serves as a trigger for 
nuclear translocation of both MRTF-A and YAP (Fig. 3-2). The role of cell-cell junctions in 
general, and of VE-Cadherins in particular, in regulating YAP subcellular localization has been 
described by Giampietro et al 99. We could confirm part of this work with our VE-cadherin 
blocking experiments and furthermore observed a functionally similar, though kinetically 
distinct response for MRTF-A (Fig. 3-3). Our present work thus expands the regulatory impact 
of VE-Cadherins on endothelial mechanosensing to the MRTF-SRF axis. Of note, the 
involvement of cadherin family proteins in the regulation of SRF is presumably not limited to 
VE-Cadherins. Busche et al. have reported similar findings for epithelial cell cadherins 100. 
Moreover, a recent study by Row et al. highlighted the role of Cadherin-11 as an upstream 
regulator of MRTF-A in vivo 101. 
Apart from their shared sensitivity towards cell-cell contacts, nuclear levels of both MRTF-A 
and YAP were influenced by the provided adhesive surface (Fig. 3-4). This was confirmed on 
a transcriptional level by the significantly reduced expression of MRTF-A and YAP target genes 
in a low-adhesive microenvironment (Fig. 3-4). In agreement with the findings reported here, 
Plessner et al. recently established a connection between integrin signaling, Rho GTPase 
activation and SRF-mediated transcription 102. Consistently, Hermann et al. demonstrated that 
integrins synergize to trigger the expression of the invasion-promoting SRF target gene ISG15 
(Interferon-stimulated gene 15) 103.  
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Similar as for MRTF-A, we observed a clear correlation between adhesive square size and 
nuclear levels of the transcription factor YAP. The mechanism underlying this regulation is still 
incompletely understood. Zhao et al. previously showed that cell detachment initiates Lats1/2 
kinase activity, and therefore YAP phosphorylation and cytoplasmatic retention, in MCF10A 
cells 104. Mechanistically, a direct connection between integrins and Hippo signaling has been 
suggested 105. Due to the correlated behavior of both transcription factors on our square 
patterns, it is likely that integrins are a shared regulator of MRTF-A and YAP. Whether the 
activity of MRTF-A and YAP is ultimately regulated by the surface area or by the number of 
adhesive sites remains an open question. To address this issue, topographic micropatterns 
with a controlled number of adhesion sites could be used 106. 
As a third parameter, we tested how a variation of cell shape would affect the subcellular 
localization of both transcription factors (Fig. 3-5). Although nuclear levels of MRTF-A and YAP 
were reduced in comparison to an unconfined control setting, we did not observe a shape-
dependent regulation within the range of tested micropatterns. Interestingly, O´Connor et al. 
have reported a shape factor-dependent regulation of the SRF target TGF-ß in epithelial cells 
under similar, though not completely identical experimental conditions 107. On the other hand, 
a global analysis of gene expression patterns performed by Stiles et al. concluded that spatial 
confinement per se, but not a particular cell shape, is the master regulator of an adapted 
transcriptional profile in human coronary artery endothelial cells 108. Since our observations in 
HUVEC point to a similar direction, there might be cell- or at least tissue-specific differences 
regarding the impact of cell shape on transcriptional regulation.  
 
5.1.2 A question of time: how kinetics make the difference 
 
The similar static response of MRTF-A and YAP to our different micropatterns does not allow 
to draw conclusions on potential kinetic variations in their regulation. We therefore analyzed 
translocation dynamics of both transcriptions factors during migration across a structurally 
challenging, dumbbell-shaped micropattern (Fig. 3-6). Our time-lapse imaging experiments on 
these interconnected squares revealed that MRTF-A reacts much more sensitive to this 
stimulus than YAP. Furthermore, the response of YAP to fluid shear stress was delayed 
compared to the rapid activation of MRTF-A (Fig. 3-7). In line with this, also inactivation of 
YAP, e.g. after the reformation of cell-cell contacts (Fig. 3-3), was markedly slower than in the 
case of MRTF-A.  
The hypothesis on differential regulatory kinetics of MRTF-A and YAP in endothelial cells was 
supported by immunofluorescent co-stainings of both transcription factors at different stages 
of tubular network formation. In these experiments, MRTF-A expression levels were 
considerably reduced at nodal points of the inner network compared to the dynamic border 
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regions already after two hours (Fig. 3-8). The reduction of total expression levels was 
accompanied by a significant drop in nuclear MRTF-A levels within confluent areas. However,  
we did not observe an equally rapid inactivation for YAP, which exhibited less pronounced 
differences in subcellular localization between outer and inner regions. The slow regulation of 
YAP was further reflected by a more consistent expression over time, resulting in a time-
dependent variation of its correlation to MRTF-A expression (Fig. 3-8).  
Our direct comparison of translocation dynamics, expression levels and subcellular localization 
of MRTF-A and YAP implicates that the kinetics and sensitivity of activation and inactivation 
are two of the most striking differentiators in the regulation of both transcription factors. In line 
with our present data for primary endothelial cells, Cui et al. have reported that MRTF-A is 
activated much faster than YAP when fibroblasts are subjected to cyclic stretching forces 109. 
In their experiments YAP activation was delayed by several hours when compared to the rapid 
nuclear translocation of MRTF-A 109. More recently, a study of the Posern group showed that 
a  precise temporal control of MRTF-A is functionally required for the formation of mammary 
acini 24, thus highlighting the importance of MRTF-A regulation for spatiotemporally 
coordinated developmental processes.  
Taken together, the results described in section 3.2 demonstrate that MRTF-A and YAP exhibit 
different kinetics in terms of their activation and inactivation. The regulatory aspects of both 
transcription factors, as described in sections 3.1 and 3.2., are summarized in the proposed 
regulatory scheme below (Fig. 5-1). 
 
 
Figure 5-1 | Regulatory model of MRTF and YAP mechanosensing in endothelial cells 
 
 
Based on the findings reported in the first part of this thesis, we suggest that - regardless of 
their shared activating stimuli – MRTF-A and YAP serve distinct functions in the regulation of 
angiogenesis. Due to its direct coupling to the polymerization state of actin (ref. section 2.2.2), 
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MRTF-A could fulfill the role of a fast-responding mechanosensitive switch, which is rapidly 
activated at nascent sprouts and required for the highly dynamic process of tip cell invasion. 
In turn, the limited responsiveness of YAP to cytoskeletal remodeling points to the direction 
that this transcription factor could, once activated, serve to sustain a basal proliferative activity 
of endothelial cells during vessel development and maturation. On a functional level, this 
hypothesis is supported by the time-dependent expression of MRTF-A and YAP target genes 
in our transcriptomic approach (Fig. 3-7) and by the different expression patterns of both 
transcription factors in the developing murine retina (Fig. 3-9). 
 
5.1.3 Master regulator or one out of many? The relationship between actin and YAP 
 
A possible explanation for the divergent regulatory kinetics of MRTF-A and YAP can be found 
by looking at the differential role of actin in these two signaling cascades. In case of MRTF-A, 
its subcellular localization is directly coupled to the F- / G-actin equilibrium 110. On the other 
hand, YAP is indirectly influenced by actin polymerization – presumably via angiomotins 90,111. 
Moreover, the canonical Hippo cascade is regulated by a variety of different stimuli 31, which 
could at least partially annul each other or counteract the cytoskeletal influence. A 
physiological example for the complex influence of mechanical stimuli on YAP activity is given 
by its response to shear stress, which has been controversially discussed. Nakajima et al. 
reported that YAP is activated by fluid shear stress to promote vascular maintenance 38. In 
contrast, Xu et al. suggested that atheroprotective laminar flow would ultimately inhibit YAP in 
endothelial cells 112. Therefore, it might be possible that YAP is only activated in response to 
distinct mechanical cues. This has been suggested for disturbed flow conditions by Wang and 
colleagues 113. Interestingly, YAP could be rapidly activated in our cells with thrombin (Fig. 4-
9), pointing to the direction that its activation is not generally slow but rather dependent on the 
respective physiological context. 
In any case, it will be important to answer the question whether there are upstream regulators 
of Hippo-YAP/TAZ that are completely independent from actin and other mechanical aspects. 
A possible pool of candidates is represented by the extensive group of G-protein coupled 
receptors, which can either activate or inactivate the Hippo pathway kinase Lats1/2 30,31.  
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5.2 Actin polymerizers and mechanosensing: surprising selectivity 
5.2.1 Miuraenamide A reveals the difference between MRTF and YAP 
 
Apart from its distinct effect on nuclear actin levels, Miuraenamide A was identified as a potent 
activator of the mechanosensitive transcription factor MRTF-A (Fig. 4-9 and Fig. 4-10). This 
was to be expected, since monomeric actin serves as the direct and main regulator of MRTF-
A 16,17. More remarkably, subcellular localization and thus activity of the actin-dependent 
transcription factor YAP remained unaffected by Miuraenamide A.  
A regulatory connection between the actin cytoskeleton and YAP / TAZ has been extensively 
described 31,91,92. However, the underlying mechanism is not fully understood. Several research 
groups have demonstrated that the actin cytoskeleton is a major upstream regulator of the 
Hippo-YAP / TAZ pathway 114. Still, it is not entirely clear whether a reduced activity of the 
canonical Hippo pathway kinases is mandatory or optional for actin-mediated activation of YAP 
111,115. In this regard, our data points to the direction that actin polymerization per se does not 
necessarily interfere with YAP phosphorylation, regardless of whether the polymers are 
ultimately organized as a filamentous network or aggregate-like. In our experiments, a reduced 
interaction between AMOTp130 and YAP was sufficient to increase nuclear YAP levels 
independently from phosphorylation (Fig. 4-9 and Fig. 4-11). In line with previous work by 
Mana-Capelli et al., we therefore suggest that reduced Hippo pathway activity might act as an 
enhancer of actin-mediated YAP activation rather than being a prerequisite 90.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2 | Proposed regulatory model underlying the differential response of MRTF-A and YAP 
to Miuraenamide A-induced actin aggregation 
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Based on our results, we developed the regulatory model shown in Fig. 8. In brief, our model 
states that the structure of polymerized actin decides over its ability to trigger nuclear 
translocation of YAP via cytoskeletal remodeling. In turn, our findings support the role of F-
actin as a binding scaffold for the YAP inhibitory protein AMOTp130 116.  
MRTF-A and YAP are known for sharing a variety of target genes, such as CCN1 or CTGF 97. 
Moreover, a crosstalk between MRTF-A and YAP has recently been reported to be causative 
for the development of breast cancer metastasis 98. Similar findings by Speight et al. 
demonstrated a context-dependent switch in chemo- and mechanotransduction between 
MRTF-A and the YAP-related protein TAZ 117. In this context, Miuraenamide A provides an 
interesting possibility for selective targeting of the MRTF-SRF signaling axis. 
 
5.2.2 Actin binding compounds as cell biological tools: chances and pitfalls 
 
On the one hand, our results showed that actin stabilizers, such as Miuraenamide A, are 
adequate tools to deplete endogenous G-actin. In addition, the results described here identified 
actin polymerizers and depolymerizers as pharmacological tools for the bidirectional 
modulation of nuclear actin levels (Fig. 4-7). In this context, it is important to mention that our 
FCS and RICS experiments prove that nuclear actin levels can be selectively altered without 
a change of intranuclear polymerization state. 
One the other hand, the present work clearly demonstrates that actin binding compounds have 
experimental limitations that need to be considered. First, due to their aggregate-like structure, 
the resulting polymers cannot be functionally equated with physiological F-actin (Fig. 4-11). 
This is particularly important when it comes to the investigation of processes that involve the 
interaction of F-actin with specific binding partners. Previous work in our lab has demonstrated 
that actin aggregation by Chondramide B, a structural relative of Miuraenamide A, can simply 
trap binding partners in the resulting actin “clumps” without a specific interaction. Second, the 
transcriptome data introduced in Fig. 4-1 and Fig. 4-2 brought up a number of genes that are 
not directly connected to altered actin dynamics. Thus, it should be kept in mind that – similar 
to most other compounds - actin binders can have off target effects. In the case of actin 
polymerizing drugs, this issue is difficult to address, since most of these compounds share a 
common cyclic depsipetide backbone (ref. section 2.4.1) and are thus likely to share common 
off target effects.  
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5.3 Actin binding compounds predominantly act in the cytoplasm 
5.3.1 Nuclear actin and transcription: a matter of concentration? 
 
In the experiments described here, transcription was regulated by actin binding compounds at 
concentrations that affected the quantities of nuclear actin, but not its polymerization state 
(Fig. 4-5, Fig. 4-6). Our data thus implicates that, in order to manipulate transcriptional events, 
nuclear actin does not necessarily need to polymerize or depolymerize. Other examples that 
highlight the regulatory importance of nuclear actin levels rather than polymerization state, 
include but are not limited to the work of Spencer et al. 51 and two studies of the Vartiainen lab 
44,118. Second, our findings suggest that intranuclear actin polymerization does not significantly 
contribute to the mode of action of actin binding compounds. Nevertheless, this does not 
exclude the possibility that intranuclear actin polymerization is relevant in other physiological 
contexts such as DNA damage response, mitosis or spreading 47,119-121.  
Nuclear and cytoplasmatic actin pools are in a dynamic equilibrium, which is maintained via 
an active transport mechanism mediated by importin 9 and exportin 6 44,45. Since actin can 
only enter or exit the nucleus in monomeric form, we assume that an interference with the 
cytoplasmatic polymerization state of actin can shift the steady state distribution of actin 
monomers between both compartments. As it is shown in the regulatory model presented in 
Fig. 5-3., we suggest that the change in nuclear actin concentration is a secondary result of 
an altered cytoplasmatic G-actin availability and thus nuclear import rates.  
 
 
 
 
 
 
 
 
 
 
5.3.2 Transcriptional effects of actin binding compounds: The cytoplasm sets the tone 
 
We observed that extremely high concentrations of Miuraenamide A can induce nuclear actin 
aggregation in NLS-actin overexpressing cells (Fig. 4-8). However, the endogenous amount 
of readily accessible intranuclear actin monomers was insufficient to trigger polymerization 
Nucleus Cytoplasm 
Figure 5-3 | Proposed model for the response of nuclear versus cytoplasmatic actin to polymerizing 
and depolymerizing actin binding compounds. 
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with Miuraenamide A at any concentration. Since the cytoplasmatic concentration of actin is in 
the micromolar range 122, we assume that actin binding compounds are preferentially bound in 
the cytoplasm. In turn, these compounds are unable to reach the nucleus in sufficient quantities 
within the timescale required to influence transcriptional regulation via actin polymerization.   
 
5.4 Outlook and future perspectives 
5.4.1 Transcriptional targets beyond MRTF 
 
MRTF-SRF signaling accounts for many, but by far not for all of the genes regulated in our 
transcriptomic analysis (Fig. 4-1, Fig. 4-2). In this context, the drastic changes in nuclear shape 
and chromatin structure induced by actin binding compounds provide an interesting track for 
further investigation (Fig. 4-3). It is well established that chromatin architecture is reorganized 
in response to cytoskeletal destabilization 10,12,123. However, to our knowledge, very little is 
known about gene sets that are specifically regulated by changes in nuclear shape or a 
disruption of the LINC complex.  
Elosegui-Artola et al. have recently described the nuclear entry of YAP in force-deformed cell 
nuclei 124. Although both Miuraenamide A and Latrunculin B severely affected nuclear shape 
in our experiments (Fig. 4-3), we did not see any activation of YAP in either case (Fig. 4-9). An 
explanation for this could be that nuclear pore size is differently affected in nuclei which are 
deformed by force compared to cytoskeletal destabilization through actin binding compounds. 
To our knowledge, very little is known about gene sets that are specifically regulated by 
changes in nuclear shape 125,126. Still, the nuclear deformation induced by actin binding 
compounds could be responsible for the regulation of distinct gene sets in our transcriptomic 
approach. Next to the use of actin binding compounds, a transient induction of nuclear 
deformation can be achieved with the dumbbell-shaped patterns introduced in Fig. 3-6. In 
combination with live cell mRNA probes, such as SmartFlareTM reagents, the dynamic 
transcription of force-dependent genes could be studied (Fig. 5-4). 
 
 
 
 
 
 
 
 
 
 
Direction of movement 
Figure 5-4 | Nuclear deformation during migration across dumbbell-shaped micropatterns. 
For visualization of cell nuclei, HUVEC were transiently transfected with nAC-GFP carrying plasmid 
constructs. 
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5.4.2 Temporal control of microadhesive surfaces 
 
Our results showed that the regulatory differences between MRTF-A and YAP are mainly 
based on kinetic aspects. Switchable micropatterns could provide an experimental route to 
further investigate this finding with adequate temporal resolution. 
In general, temporally controllable micropatterns can be generated by purely chemical, 
combined photochemical or thermosensitive substrate approaches 127. A frequently used 
method involves the covalent coupling of protein-repellent PLL-PEG to azide groups 128. By in 
situ Huisgen reaction with cycloocytnes, these surfaces are rendered adhesive under 
biocompatible conditions 129.  
Although the abovementioned strategy can be used to trigger dynamic processes like 
collective cell migration, it lacks the spatial resolution required to study cytoskeletal remodeling 
in single cells. To further elucidate the kinetics of MRTF-A and YAP nuclear translocation in 
single endothelial cells, photoswitchable surfaces could be used. For example, the provided 
adhesive surface area could be incrementally increased by local laser ablation of 
photocleavable PLL-PEG derivatives 130. In combination with live cell imaging of fluorescently 
labeled transcription factors, this would allow for a real-time analysis of MRTF-A and YAP 
subcellular localization in response to defined microenvironmental alterations. 
 
5.4.3 Let there be light: a route for selective targeting of nuclear actin 
 
Due to the abundancy of cytoplasmatic actin, the selective targeting of nuclear actin poses a 
significant experimental challenge. An interesting approach to overcome this obstacle is 
provided by the emerging field of optogenetics and photoswitchable reagents. In 2002, Nagel 
et al. reported that the expression of Channelrhodopsin-1, an ion channel found in green algae, 
produced light-gated conductance in Xenopus laevis oocytes 131. In the following years, 
optogenetic techniques were further developed and successfully used in neurosciences 132. In 
2017, Baarlink et al. showed that nuclear actin depolymerization can be inhibited by the 
expression of an optogenetic cofilin-1 derivative 119.  
A closely related possibility for the selective targeting of intranuclear actin could be the 
development of photoswitchable actin binding compounds. In 2015, Borowiak et al. 
demonstrated that mitosis and cell death can be optically controlled by photostatins, a novel 
group of photoswitchable microtubule inhibitors 133. Given the availability of suitable molecular 
candidates, this concept could be transferred to target other cytoskeletal components, such as 
intermediate filaments or actin.  
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5.5 Summary and Conclusion 
 
In conclusion, the first part of this thesis provides a systematic comparative analysis of 
microenvironmental cues for the mechanosensitive regulation of blood vessel formation. 
Based on the application micropatterning techniques as a tool to mimic mechanobiological 
aspects of angiogenesis, we identify the loss of cell-cell contacts and changes in adhesive 
surface as major regulators of both MRTF-A and YAP nuclear translocation in endothelial cells. 
Apart from these similarities, we observe that MRTF-A exhibits significantly higher 
responsiveness than YAP on a short time scale. Our results are recapitulated in two angiogenic 
model systems, corroborating the hypothesis that both transcription factors are assigned 
different tasks within the spatiotemporal regulation of angiogenesis.  
 
The second part of this study aims to investigate the transcriptional response to actin binding 
compounds in primary endothelial cells. We demonstrate that Miuraenamide A is a potent and 
selective activator of the MRTF-SRF signaling axis, since the aberrant structure of 
cytoplasmatic aggregates formed by this compound prevents the activation of other 
mechanosensitive signaling pathways such as Hippo-YAP/TAZ. In turn, these findings 
emphasize that not every actin-dependent cellular process can be mimicked with actin binding 
compounds. Second, our data shows that, although actin binding compounds interfere with 
the quantities of nuclear actin, intranuclear polymerization state and transcriptional 
machineries in the nucleus remain largely unaffected. Thus, we conclude that actin binding 
compounds regulate transcription via the cytoplasm rather than the nucleus. 
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6 Material and Methods 
 
6.1 Materials 
 
6.1.1 Compounds 
 
The myxobacterial compound Miuraenamide A was provided by the lab of Prof. Uli Kazmaier 
(Institute for Organic Chemistry, Saarland University, Saarbrücken, Germany) 66. 
Chivosazole A was isolated from myxobacteria in the lab of Prof. Rolf Müller (Helmholtz 
Institute of Pharmaceutical Research Saarland, Saarbrücken, Germany). Both compounds 
were stored at -20 °C as 10 mM DMSO stock solutions and used at working concentrations 
between 50 - 100 nM containing < 0.1% DMSO.  
Latrunculin B and Jasplakinolide were both purchased from Sigma (Taufkirchen, Germany) 
and handled according to the manufacturer’s instructions.  
 
6.1.2 Chemicals and reagents 
 
The following table contains a list of all chemicals, reagents and kits used in this study. 
Antibodies (6.1.2.1), buffers and solutions (6.1.2.2) and plasmids (6.2.5) are listed separately. 
 
Table 1 Chemicals and reagents 
Reagent Company 
0.05% Bromophenol blue Sigma-Aldrich, Taufkirchen, Germany 
16% formalin, EM-grade Polysciences Inc., PA, USA 
5% Blotto solution Thermo Scientific, MA, USA 
AffiniPure Fab fragments Jackson Immunoresearch, PA, USA 
Amersham ECL Reagent GE Lifesciences, Chalfont St Giles, UK 
Amphotericin B PAN Biotech, Aidenbach, Germany 
Ampicillin Sigma-Aldrich, Taufkirchen, Germany 
APS Thermo Scientific, MA, USA 
ATTO488 dye ATTO-TEC GmbH, Siegen, Germany 
Bovine serum albumin (BSA) Sigma-Aldrich, Taufkirchen, Germany 
Bradford Roti® Quant reagent Bio-Rad, Munich, Germany 
Collagen G Biochrom AG, Berlin, Germany 
Complete® protease inhibitor Roche Diagnostics, Penzberg, Germany 
Dimethylsulfoxide (DMSO) Sigma-Aldrich, Taufkirchen, Germany 
DNAseI-AlexaFluor 488 Thermo Scientific, MA, USA 
DNAseI, RNAse-free Thermo Scientific, MA, USA 
Dulbecco’s Modified Eagle Medium (DMEM) PAA Laboratories, Pasching, Austria 
Duolink® PLA kit and PLUS / MINUS probes Sigma-Aldrich, Taufkirchen, Germany 
Endothelial cell growth medium Pelobiotech GmbH, Martinsried, Germany 
Ethylendiaminetetraacetic acid (EDTA) Sigma-Aldrich, Taufkirchen, Germany 
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Reagent Company 
Ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich, Taufkirchen, Germany 
Exonuclease I  Thermo Scientific, MA, USA 
Fetal calf serum (FCS) Biochrom AG, Berlin, Germany 
Fibronectin Corning, NY, USA 
FluorSave® reagent mounting medium Merck, Darmstadt, Germany 
Glutaraldehyde 50% Fluka Biochem, Taufkirchen, Germany 
Glycerol Applichem¸ Darmstadt, Germany 
High-Capacity cDNA Reverse Transcription Kit Applied Biosystems, Waltham, USA 
Hoechst 33342 Sigma-Aldrich, Taufkirchen, Germany 
IB4-AlexaFluor 488 Thermo Scientific, MA, USA 
IGEPAL CA-630 Sigma-Aldrich, Taufkirchen, Germany 
Kanamycin Sigma-Aldrich, Taufkirchen, Germany 
KAPA HiFi HotStart polymerase KAPA Biosystems, MA, USA 
LB agar powder Invitrogen, CA, USA 
LB broth powder Invitrogen, CA, USA 
MatrigelTM REF 356231 Corning, NY, USA 
Nextera XT Kit Illumina, CA, USA 
PageRuler™ Plus Prestained Protein Ladder Fermentas, St. Leon-Rot, Germany 
Penicillin / Streptomycin 100x PAN Biotech, Aidenbach, Germany 
Phenymethylsulfonyl fluoride (PMSF) Sigma-Aldrich, Taufkirchen, Germany 
Plasmid Maxi Prep Kit QIAGEN, Hilden, Germany  
PLL(20 kDa)-g[3.5]-PEG(2 kDa) Surface Solutions, Dübendorf, Switzerland 
Polyacrylamide Carl Roth, Karlsruhe, Germany 
Potassium dihydrogen phosphate Carl Roth, Karlsruhe, Germany 
PowerUp™ SYBR® Green Master Mix Applied Biosystems, MA, USA 
Protein G agarose suspension Roche, Basel, Switzerland 
Pyronin Y Sigma-Aldrich, Taufkirchen, Germany 
Rhodamine/Phalloidin Sigma-Aldrich, Taufkirchen, Germany 
RNeasy® Mini Kit (250) QIAGEN, Hilden, Germany 
RotiphoreseTM Gel 30 Carl Roth, Karlsruhe, Germany 
Sera-Mag carboxylated magnetic beads Thermo Scientific, MA, USA 
Sodium borohydride Sigma-Aldrich, Taufkirchen, Germany 
Sodium chloride Carl Roth, Karlsruhe, Germany 
Sodium deoxycholate Carl Roth, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Carl Roth, Karlsruhe, Germany 
Sodium fluoride (NaF) Merck, Darmstadt, Germany 
Sodium hydrogen phosphate Carl Roth, Karlsruhe, Germany 
Sodium orthovanadate (Na3VO4) ICN Biomedicals, OH, USA 
Sodium pyrophosphate Sigma-Aldrich, Taufkirchen, Germany 
ß-Glycerophosphate Sigma-Aldrich, Taufkirchen, Germany 
ß-Mercaptoethanol Sigma-Aldrich, Taufkirchen, Germany 
Sylgard 184 Silicone Elastomer Kit Corning, NY, USA 
Targefect-HUVECTM Targeting Systems, CA, USA 
TEMED Thermo Scientific, MA, USA 
Tris Base Sigma-Aldrich, Taufkirchen, Germany 
Tris HCl Sigma-Aldrich, Taufkirchen, Germany 
Triton X-100 Sigma-Aldrich, Taufkirchen, Germany 
Trypsin PAN Biotech, Aidenbach, Germany 
Tween 20 Sigma-Aldrich, Taufkirchen, Germany 
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6.1.2.1 Antibodies 
 
The following tables contain all antibodies used in this study. Primary and secondary 
antibodies are listed separately. 
 
Table 2 Primary antibodies  
Name Species Catalogue Manufacturer Dil. Fc. IF / WB 
Angiomotin (D2O4H)  rabbit mAb IgG #43130 CST       -   / 1:1000 
Anti-ACTB mouse mAb IgG1 AMAB91241 Sigma 1:100 (Duolink) 
Anti-BrdU Clone BU-33 mouse mAb IgG B8434 Sigma 1:500 /   - 
HA-Tag (6E2) mouse mAb IgG1 #2367 CST 1:150 / 1:1000 
HistoneH3 (acetyl K9)  mouse mAb IgG1 ab12179 Abcam       -   / 1:1000 
HistoneH3 (dimethyl K4) mouse mAb IgG1 25254 BPS       -   / 1:1000 
HistoneH3 (trimethyl K4) mouse mAb IgG1 ab12209 Abcam       -   / 1:1000 
HistoneH3 total rabbit polyclonal ab1791 Abcam       -   / 1:1000 
MRTF-A mouse mAb IgG2a sc-390324 SCBT 1:150 /   - 
POLR1A (Polymerase I) rabbit mAb IgG1 HPA031513 Sigma 1:100 (Duolink) 
VE-Cadherin D87F2 rabbit mAb IgG #2500 CST 1:150 /   - 
VE-CadherinECD mouse mAb IgG2a MABT134 Merck 1:100 (blocking) 
YAP (B-8) mouse mAb IgG2a sc-398182 SCBT 1:150 / 1:1000 
YAP XP® D8H1X rabbit mAb IgG #14074 CST 1:150 / 1:1000 
 
 
Table 3 Secondary antibodies, HRP- and IF-conjugates 
Name Species Catalogue Manufacturer Dilution 
AlexaFluor 488 goat anti-mouse A-11001 Thermo Scientific 1:500 
AlexaFluor 647 goat anti-rabbit A-21245 Thermo Scientific 1:500 
AlexaFluor 546 goat anti-mouse A-11030 Thermo Scientific 1:500 
HRP conjugate goat anti-rabbit #1706515 Bio-Rad 1:1000 
HRP conjugate goat anti-mouse BZL07046 Biozol 1:1000 
 
 
6.1.2.2 Buffers and solutions 
Table 4 Buffers and solutions 
Separation gel (pH 8.8)  Stacking gel (pH 6.8) 
RotiphoreseTM Gel 30 25/33/40/50%  RotiphoreseTM Gel 30 17% 
Tris base 375 mM  Tris HCl 125 mM 
SDS 0.1%  SDS 0.1% 
TEMED 0.1%  TEMED 0.2% 
APS 0.05%  APS 0.1% 
H2O   H2O  
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Electrophoresis buffer  Tank buffer 
Tris base 4.9 mM  Tris base 48 mM 
Glycine 38 mM  Glycine 39 mM 
SDS 0.1%  Methanol 20% 
H2O   H2O  
 
Standard lysis buffer  5x SDS sample buffer (pH 6.8) 
Tris HCl 50 mM  Tris HCl 3.125 M 
NaCl 150 mM  Glycerol 50% 
IGEPAL CA-630 1%  SDS 5% 
Sodium deoxycholate 0.25%  DTT 2% 
SDS 0.10%  Pyronin Y 0.025% 
Na2VO4 300 µM  H2O  
NaF 1 mM    
β-Glycerophosphate 3 mM  NP-40 lysis buffer  
Pyrophosphate 10 mM  NaCl 150 mM 
H2O   IGEPAL CA-630 1% 
before use:   Tris HCl 50 mM 
Complete® protease inh. 4 mM  Sodium deoxycholate 0.25% 
PMSF 1 mM  EGTA 1 mM 
H2O2 600 µM  H2O  
   before use:  
   PMSF 1 mM 
   Complete® protease inh. 1:10 
 
PLA Washing buffer A (pH 7.4)  PLA Washing buffer B (pH 7.5) 
Tris base 10 mM  Tris base 35 mM 
NaCl 150 mM  NaCl 100 mM 
Tween 20 0.05%  Tris HCl 165 mM 
H2O   H2O  
 
Cytoskeleton Stabilizing buffer  PBS (pH 7.4) 
Tris base 4.9 mM  NaCl 137 mM 
Glycine 38 mM  KCl 2.7 mM 
SDS 0.1%  Na2HPO4 10 mM 
H2O   KH2PO4 1.8 mM 
   H2O  
 
TBS-T (pH 7.6)  
Tris HCl 50 mM  
NaCl 150 mM  
Tween 20 0.1%  
H2O   
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6.1.3 Technical equipment 
 
Table 5 Technical devices and lab equipment 
Device Name Manufacturer 
Axiovert 25/200 microscope Zeiss, Jena, Germany 
Bold Line incubation system Okolab, Pozzuoli, Italy 
ChemiDoc™ Touch imaging system Bio-Rad GmbH, Dreieich, Germany 
Digital UV Ozone Cleaner system Novascan, IA, USA 
HERACell 150i incubator Thermo Scientific, MA, USA 
HiSeq1500 sequencing device Illumina, CA, USA 
ibidi Gas Incubation system ibidi, Martinsried, Germany 
ibidi Heating system ibidi, Martinsried, Germany 
ibidi Pump system ibidi, Martinsried, Germany 
Megafuge 1.0 RS centrifuge Thermo Scientific, MA, USA 
Mikro 220R centrifuge Hettich, Bäch, Switzerland 
Mini PROTEAN 3 electrophoresis chambers Bio-Rad GmbH, Dreieich, Germany 
Mini Trans-Blot® system Bio-Rad GmbH, Dreieich, Germany 
Nanodrop® 1000 spectrophotometer PEQLAB Biotechnologie GmbH 
Nikon Eclipse Ti inverted microscope Nikon, Düsseldorf, Germany 
Orion II microplate luminometer Titertek Berthold, Bad Wildbad, Germany 
Peqlab heating block VWR, Bruchsal, Germany 
Power Pac 300 blotting device Bio-Rad GmbH, Dreieich, Germany 
QuantStudio™ 3 Real-Time PCR system Applied Biosystems, MA, USA 
SpectraFluor Plus™ plate reader Tecan, Crailsheim, Germany 
TCS SP8 SMD confocal microscope Leica Microsystems, Wetzlar, Germany 
Vi-Cell™ XR cell counter Beckman Coulter, CA, USA 
Vibrax VXR basic lab shaker IKA, Staufen, Germany 
 
6.1.4 Consumables 
 
Table 6 Consumables 
Product Manufacturer 
Cell culture dish, 60.1 cm2 and flasks, 75 cm2 TPP, Trasadingen, Switzerland 
Disposable pipettes: 5 ml, 10 ml, 25 ml Greiner Bio, Frickenhausen, Germany 
Falcon tubes: 15 ml, 50 ml VWR, Bruchsal, Germany 
MicroAmp® Fast Optical 96 Well plate, 0.1 mL Applied Biosystems, MA, USA 
MicroAmp® Optical Adhesive Film Applied Biosystems, MA, USA 
Microtiter plates: 6 well, 12 well, 96 well Greiner Bio, Frickenhausen, Germany 
Nitrocellulose membrane (0.2 µM) Hybond-ECLTM Amersham Bioscience, Freiburg, Germany 
PCR tubes Eppendorf, Hamburg, Germany 
Pipette tips: 10 µl, 100 µl, 1000 µl Sarstedt, Nümbrecht, Germany 
Polyvinylidene difluoride (PVDF) membrane  Amersham Bioscience, Freiburg, Germany 
Safe-Lock Tubes: 0.5 ml, 1.5 ml, 2.0 ml Eppendorf, Hamburg, Germany 
µ-Slide 18 well ibitreat ibidi, Martinsried, Germany 
µ-Slide 8 well (glass, ibitreat, uncoated) ibidi, Martinsried, Germany 
µ-Slide Angiogenesis ibidi, Martinsried, Germany 
µ-Slides I 0.4 Luer ibidi, Martinsried, Germany 
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6.2 Methods 
 
6.2.1 Cell culture 
6.2.1.1 Cell lines and culture media 
 
All cells were cultivated at 37 °C and high humidity under 5% CO2 atmosphere. Cell culture 
media were supplemented with 1% penicillin / streptomycin and amphotericin B. 
Human umbilical vein endothelial cells (HUVEC) were purchased from Promocell. Cells were 
cultivated with endothelial cell growth medium from PELO Biotech supplemented with ECGM 
Kit enhanced and 10% FCS. All experiments were performed in passage #6. 
NIH3T3 cells were purchased from Sigma-Aldrich and cultivated with DMEM supplemented 
with 10% FCS. To ensure equal adhesive conditions across different assay formats, fibronectin 
coated surfaces were used in all experiments. 
 
6.2.1.2 Cell counting and passaging 
 
For detachment of adherent cells, the growth medium was removed and cells were shortly 
rinsed with prewarmed PBS. After 5 min incubation with trypsin / EDTA at 37 °C, tryptic 
digestion was stopped by the addition of standard growth medium. Cells were centrifuged at 
1.000 rpm for 5 min and the pellet was resuspended in full growth medium. 
Cells were counted using a ViCellTM XR cell counter. Upon reaching confluence, cells were 
either split 1:2 into 75 cm2 cell culture flasks or seeded at subconfluent densities for further 
experiments. 
 
6.2.2 Microcontact printing 
 
For the generation of microadhesive surface patterns, silicon template wafers carrying the 
desired microfeatures were generated in the lab of Prof. Joachim Rädler (Chair for Soft 
Condensed Matter, LMU, Munich). Polydimethylsiloxane (PDMS) stamps were crafted by 
pouring a 10:1 mixture of the monomer and its crosslinker on top of these wafers. After removal 
of air bubbles under vacuum atmosphere, the samples were left overnight for polymerization 
at 50 °C. The resulting PDMS stamps were cut out with a scalpel and hydrophilized for 20 min 
using a commercially available UV ozone cleaner. Stamps were coated with 50 µg/ml 
fibronectin for 2 h and excess protein solution was removed by rinsing with sterile H2O. The 
protein pattern was then transferred onto the surface of uncoated µ-Slides 8 well via 
microcontact printing (µCP, 1 h). Surrounding areas were blocked for cell adhesion by 15 min 
incubation with a sterile aqueous solution of 1 mg/ml PLL(20kDa)-g[3.5]-PEG(2kDa). Excess 
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PLL(20kDa)-g[3.5]-PEG(2kDa) solution was removed by short rinsing with PBS. 200 µl cell 
suspension (5000 cells / well) were added to each well and after cell attachment, the medium 
was changed to remove residual unattached cells.  
 
 
Figure 6-1 | Microcontact printing workflow 
 
6.2.3 Confocal Imaging 
 
Confocal images were acquired using a Leica TCS SP8 SMD microscope equipped with hybrid 
detectors (Leica HyD) and the following HC PL APO objectives: 40x / 1.30 OIL, 63x / 1.40 OIL, 
63x / 1.20 W CORR. Pinhole size was adjusted to 1.0 airy units and scanning was performed 
between 400-600 Hz. An average of four frames was acquired for every channel in sequential 
scanning mode. The following laser lines and excitation sources were used: 405 nm (Diode), 
561 nm (DPSS), 488 nm and 647 nm (both Argon). 
 
6.2.3.1 Immunofluorescence stainings 
 
For immunofluorescence stainings, cells were shortly rinsed with PBS + Ca2+ / Mg2+ followed 
by 10 min fixation with 4% EM grade formaldehyde. After 5 min washing with PBS, samples 
were permeabilized for 10 min with 0.5% TX-100 in PBS. Unspecific binding was blocked by 
30 min incubation with 5% goat serum in PBS at RT. Cells were then incubated overnight with 
primary antibodies diluted in PBS + 0.2% BSA (4 °C). After 3 x 10 min washing with PBS, 
samples were incubated with secondary antibodies, rhodamine phalloidin (1:300) and 
Hoechst 33342 (0.5 µg/ml) for 1 hour at RT, washed again 3 x 10 min with PBS and sealed 
with one drop of FluorSave reagent mounting medium and cover slips. All stainings were 
performed in ibiTreat 8 well µ-slides coated with fibronectin. 
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6.2.3.2 Visualization of nuclear actin 
 
Nuclear actin stainings were performed with cytoskeleton stabilizing buffers (CSB) and 2% 
glutaraldehyde fixation as previously described 134. In brief, an initial 1 min prefixation with 
0.5% Triton X-100 + 0.25% glutaraldehyde in CSB was followed by 15 min fixation with 2% 
glutaraldehyde in CSB. Autofluorescence was quenched using freshly prepared 1 mg/ml 
NaBH4 solution in CSB and after repeated washing steps, samples were incubated with 
rhodamine phalloidin (1:300) and Hoechst 33342 (0.5 µg/ml) for 1 h at RT. After one additional 
washing step with PBS, samples were mounted with one drop of FluorSave reagent and sealed 
with custom cover slips.  
 
6.2.3.3 Nuclear run on assays 
 
For quantification of 5-fluorouracil (5-FU) incorporation during RNA synthesis (nuclear run on 
assay), cells were pretreated with either Miuraenamide A, Latrunculin B or Actinomycin D 
(negative control) at indicated concentrations. After incubation with a 5 mM 5-FU solution for 
the last 90 min of stimulation, samples were immunostained as described in section 6.2.3.1. 
Nuclear 5-FU foci were quantified using the ImageJ particle analyzer tool according to the 
available online instructions. 
 
6.2.3.4 Single cell F- / G-actin ratios 
 
For determination of F- / G-actin ratios, cells were co-stained with rhodamine phalloidin (1:300 
dilution, detection of F-actin) and DNAseI-AF488 (1:600 dilution), which binds G-actin 
monomers with high affinity 77. F- / G-actin levels were quantified as the quotient of total 
rhodamine phalloidin / DNAseI-AF488 signal intensity 78. The staining was performed using 
the buffers and reagents described in section 6.2.3.1. 
 
6.2.3.5 DNAse I chromatin digestion 
 
To quantify the fraction of condensed chromatin after stimulation with actin binding 
compounds, cells were fixed with cold methanol for 10 min.  Subsequently, accessible 
chromatin regions were digested for 2 h at 37 °C using 1 unit of DNAse I per well. Undigested 
DNA was visualized with Hoechst 33342 (0.5 µg/ml) and cellular heterochromatin content was 
quantified as total signal intensity of each image divided by the respective cell number. 
Untreated samples with and without DNAse I digestion were used for normalization and as 
negative controls. 
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6.2.4 Angiogenesis assays 
6.2.4.1 Tube formation assay 
 
Tube formation assays were performed in µ-Slides Angiogenesis from ibidi. 11 x 103 HUVEC 
were seeded onto thin layers of polymerized MatrigelTM (REF 356231) and the samples were 
incubated for appropriate time spans at 37 °C, 5% CO2 and high humidity. 
For immunofluorescence stainings of tube formation samples, cells were initially washed with 
PBS + Ca2+ / Mg2+ and subsequently fixed with 4% EM grade formaldehyde in PBS for 40 min. 
Samples were permeabilized for 20 minutes with 0.5% TX-100 in and unspecific binding was 
blocked by overnight incubation (4 °C) with 5% goat serum in PBS supplemented with 30 µg/ml 
anti-mouse AffiniPure Fab fragments. After 20 min washing with PBS + 0.2% BSA, samples 
were incubated overnight (4 °C) with primary antibodies diluted in PBS + 0.2% BSA. 
Subsequently, cells were washed 3 x 20 min with PBS + 0.2% BSA and secondary antibodies, 
Hoechst 33342 (0.5 µg/ml) and rhodamine phalloidin (1:300) were added. After overnight 
incubation at 4 °C, samples were again washed 3 x 20 min and one drop of FluorSave 
mounting medium was added 1 h before imaging. 
 
6.2.4.2 Retinal whole-mount stainings 
 
Wild-type C57BL/6 pups (n = 4) were sacrificed at postnatal day 6 (P6). The preparation and 
staining of murine retinas was performed as previously described by Pitulescu et al 135. In brief, 
eyeballs were removed and fixed for 2 h in 4% EM grade formaldehyde in PBS. After retinal 
preparation, retinas were blocked and permeabilized for 2 h at RT with 1% BSA, 0.3% TX-100 
in PBS. Retinal vasculature was labelled using an IsolectinB4-AlexaFluor 488 conjugate. 
Overnight incubation with primary antibodies targeting MRTF-A and YAP was followed by 
several washing steps and addition of secondary antibodies. Nuclei were visualized with 
Hoechst 33342 (0.5 µg/ml) and after two more washing steps, retinas were mounted in 
uncoated µ-slides 8 well using FluorSave mounting medium. All animal procedures were 
approved and controlled by the local Ethics Committee and carried out according to the 
guidelines of the German law of protection of animal life. 
 
6.2.5 Plasmids and transfections 
 
Primary endothelial cells were transiently transfected using the commercially available 
Targefect-HUVECTM transfection system at serum-free conditions according to the 
manufacturer’s instructions. One day prior to transfection, 125.000 cells / ml were seeded in 
CollagenG coated 6 well plates or in 8 well µ-slides. A total amount of 1.2 µg plasmid DNA 
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was used per well and cells were subjected to the transfection mixture for 2 h. Live cell imaging 
and all other experiments were performed between 24 - 48 h after transfection. 
 
Table 7 Plasmid constructs 
Name Insert Backbone Bac. Res. Company 
8xGTIIC-luciferase TEAD reporter pGL3b Ampicillin Addgene #34615 
HA-AMOT p130 AMOTp130 pcDNA3-HA Ampicillin Prof. Zhao Lab 
mCherry-C3-hYAP1 hYAP1 mod. pEGFP-C3 Kanamycin Prof. Vollmar Lab 
mCherry-ß-actin ACTB n.a. Kanamycin Addgene #54966 
MRTF-A-GFP MRTF-A n.a. Kanamycin Prof. Grosse Lab 
nAC-NLS-TagGFP VHH-Actin n.a. Kanamycin Prof. Grosse Lab 
pCAG-mGFP-ß-actin ACTB pCAG Kanamycin Addgene #21948 
pCMV-Lifeact-TagRFP Lifeact pCMV Ampicillin ibidi GmbH 
pEGFP-C3-hYAP1 hYAP1 pEGFP-C3 Kanamycin Addgene #17843 
pGL4.34[luc2P/SRF-RE] SRE reporter pGL4 Ampicillin Promega Inc. 
pGL4.74[hRluc/TK] hRluc pGL4 Ampicillin Promega Inc. 
YFP-NLS-ß-actin ACTB pEYFP-C1 Kanamycin Addgene #60613 
 
6.2.6 Live cell imaging 
 
Live cell imaging was performed at 37 °C under 5% CO2 atmosphere and 80% humidity using 
a Bold Line incubation system from Okolab. Cells were imaged 24 h after transfection.  
 
6.2.6.1 Cell migration 
 
Cell migration on dumbbell-shaped micropatterns was imaged on a Nikon Eclipse Ti Inverted 
Microscope equipped with a 4 x / 0.13 PlanFluor objective and a Cool LED pE-100 excitation 
light source. Cells were imaged at 37 °C under 5% CO2 atmosphere and 80% humidity using 
a Heating and Gas Incubation System from ibidi. 
 
6.2.6.2 Perfusion Assay 
 
Unidirectional flow cell culture experiments were performed with an ibidi Pump system. 4 x 105 
HUVEC were seeded into fibronectin-coated µ-Slides I 0.4 Luer two days before the 
experiment and transiently transfected with GFP-labelled MRTF-A or YAP 24 h before imaging.  
Shear stress was kept constant at 15 dyn / cm2, resulting in a final flow rate of approximately 
15 ml / min.  
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6.2.7 Reporter gene assay 
 
Luciferase reporter gene assays were performed using an Orion II microplate luminometer 
equipped with Simplicity analysis software. Samples were stimulated 24 - 48 h after 
transfection and analyzed in duplicates. Firefly reporter RLUs were normalized to a constitutive 
renilla control (firefly / renilla transfection ratio of 10:1) using the Dual Luciferase reporter gene 
assay kit from Promega Inc. Background luminescence was subtracted by measuring mock 
transfected control samples. 
 
6.2.8 Duolink proximity ligation assay 
 
Duolink proximity ligation assays (PLA) were performed using the Duolink® PLA kit and suitable 
PLUS / MINUS probes from Sigma-Aldrich. Storage and handling of all reagents was carried 
out according to the manufacturer’s instructions. As a blocking reagent and antibody diluent, 
2% BSA in PBS was used. PLA Washing buffers A and B were prepared as described in 0 and 
stored at 4 °C. PLA speckles were manually counted using ImageJ. 
 
6.2.9 Western blot 
6.2.9.1 Sample preparation 
 
For cell lysis, cells were shortly rinsed with cold PBS and an appropriate amount of standard 
lysis buffer was added to each well. Samples were frozen at -80 °C for minimum 30 min and 
subsequently transferred to Eppendorf tubes. To remove residual cell debris, samples were 
centrifuged at 14.000 rpm, 4 °C for 10 min. The total protein amount of each sample was 
determined using Bradford assay and the resulting concentrations were adjusted with 1x SDS 
sample buffer. Samples were then boiled for 3 min at 95 °C and stored at -20 °C until further 
usage.     
 
6.2.9.2 SDS-PAGE 
 
Proteins were separated in terms of molecular weight using discontinuous SDS polyacrylamide 
gel electrophoresis as described by Laemmli 136. In brief, equal sample amounts were loaded 
onto discontinuous separation gels with an acrylamide concentration ranging between 10 – 
15% according to the respective molecular weight of the protein of interest. Protein samples 
were initially stacked at a current of 100 V for 21 min before the actual separation was 
performed at 200 V for 45 min. The total protein amount of each lane was quantified using 
6 Material and Methods 
  63 
stain-free technology 137 and the molecular weight of the resulting bands was assessed by 
comparison with a PageRuler™ Plus Prestained Protein Ladder. 
 
6.2.9.3 Protein transfer and detection 
 
After separation, proteins were transferred onto nitrocellulose or polyvinylidene difluoride 
(PVDF) membranes by electro tank blotting 138. Membranes were pre-equilibrated in tank 
buffer for 30 min and protein transfer was carried out at 100 V, 4 °C for 90 min.  
For protein detection, membranes were first blocked for unspecific binding in 5% blotto solution 
for 2 h. Subsequently, primary antibodies were added and membranes were incubated 
overnight at 4 °C. After four washing steps with TBS-T, membranes were incubated with 
appropriate HRP-conjugated secondary antibodies for 2 h at RT. Unbound secondary 
antibodies were removed by washing 3 x 5 min with TBS-T and 5 min with H2O. 
Chemiluminescence was detected using Amersham ECL reagents and a ChemiDoc Touch 
imaging system from Bio-Rad.   
 
6.2.10 Immunoprecipitation (Co-IP) 
 
Co-IP experiments were performed using a standard NP-40 lysis buffer described in 0. All 
incubation steps were carried out under gentle agitation. After washing with cold PBS and 
subsequent addition of lysis buffer, cell lysates were scraped off the plate and transferred into 
Eppendorf tubes. Samples were centrifuged for 10 min at 9000 rpm to remove residual cell 
debris. The protein concentration of the supernatant was determined using Bradford assay 
and adjusted to equal values with NP-40 lysis buffer. A minimum of 500 µg was used for 
immunoprecipitation. Samples were incubated with 3 µg precipitation antibody for 2 h at RT 
followed by the addition of 40 µl protein G agarose suspension. After 2 h incubation at RT, 
beads were washed 3 x with 500 µl cold PBS, resuspended in 50 µl 2x sample buffer and 
boiled for 5 minutes at 95 °C. All samples were spun down using a table centrifuge and the 
supernatants were kept for Western blot analysis.  
 
6.2.11 Quantitative real-time PCR and primers 
 
Quantitative real-time PCR experiments were performed on an Applied Biosystems® 
QuantStudio™ 3 real-time PCR system. Relative changes in mRNA expression were assessed 
by the previously described ΔΔCT method 139. Samples were measured in triplicates and 
GAPDH was used as a housekeeper in all experiments. SYBRTM Green Master Mix was used 
for the detection of amplified cDNA. 
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6.2.11.1 Sample preparation 
 
mRNA was isolated from cell lysates using the RNeasy® Mini Kit from Qiagen according to 
the manufacturer’s instructions. For each of the resulting samples, mRNA concentration was 
determined on a Nanodrop® 1000 spectrophotometer. mRNA samples were stored at -80 °C. 
To generate cDNA samples from isolated mRNA, the High-Capacity cDNA Reverse 
Transcription Kit from Applied Biosystems was used according to the manufacturer’s 
instructions. cDNA samples were stored at 4 °C. 
 
6.2.11.2 Primers 
 
The following primers were purchased from Metabion (Planegg, Germany): 
 
Table 8 qPCR primers 
Target Forward Sequence Reverse Sequence 
CTGF 5'-TGGAGTTCAAGTGCCCTGAC-3' 5'-CTCCCACTGCTCCTAAAGCC-3' 
CCN1 5'-ACCCTTCTCCACTTGACCAG-3' 5'-CTTGGCGCAGACCTTACAG-3' 
GAPDH 5'-ACGGGAAGCTTGTCATCAAT-3' 5'-CATCGCCCCACTTGATTTT-3' 
hu18SrRNA 5'-CGACGACCCATTCGAACGTCT-3' 5'-CTCTCCGGAATCGAACCCTGA-3' 
SRF 5'-GTTTCAGCAGTTCAGCTCCA-3' 5'-TGTAGCTCGGTGAGGTTGCT-3' 
Vinculin 5'-GAGAGATATGCCACCAGCATT-3' 5'-GCACTGAGTAAGGGTCTGACTG-3' 
 
 
6.2.12 Transcriptomic analysis 
6.2.12.1 Sample generation 
 
Sample generation was performed by Christoph Ziegenhain (group of Prof. Wolfgang Enard). 
mRNA was cleaned up from cell lysates with Sera-Mag carboxylated magnetic beads and 
reverse transcribed using a slightly modified SCRB-seq protocol 140. During reverse 
transcription, sample-specific barcodes and unique molecular identifiers were incorporated 
into first strand cDNA. Next, samples were pooled and excess primers digested by 
Exonuclease I. 
cDNA was preamplified using KAPA HiFi HotStart polymerase from KAPA Biosystems. 
Sequencing libraries were constructed from cDNA using the Illumina Nextera XT Kit. Resulting 
libraries were quantified and sequenced at 10 nM on an Illumina HiSeq1500 sequencing 
device. To obtain gene-wise expression values, raw sequencing data was processed using 
the zUMIs pipeline 141 using the Human genome build hg19 and Ensembl gene models 
(GRCh37.75). 
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6.2.12.2 Data processing and analysis 
 
Results Part I (performed by Ludwig Geistlinger) 
 
Differential expression analysis of the obtained RNA-seq read counts was carried out using 
edgeR, which applies generalized linear models (GLMs) based on the negative-binomial 
distribution while incorporating normalization factors for different library sizes 142. Exploratory 
data analysis was carried out using the EnrichmentBrowser package 143.  
 
Results Part II (performed by Zane Kliesmete) 
 
Transcriptomic analysis was performed using the free statistical software R (v. 3.4.2). DESeq2 
package (v.1.16.1) was used for normalization and differential expression (DE) analysis. 
DESeq2 models transcriptional count data using negative binomial distribution. Additional 
filtering was done using HTSFilter (v.1.16.0) to remove constant, lowly expressed genes. The 
final gene set consisted of 15 232 genes. 
DE testing was based on Wald test. Multiple testing was accounted for by applying a global 
false discovery rate (FDR) correction to all comparisons. All genes with FDR < 0.1 were 
considered significant. 
Enrichment analysis for Gene Ontology terms was performed using topGO package (v.2.28.0), 
specifying the ontology of Biological Processes (BP). Fisher’s exact test was applied to 
measure the significance of enrichment. 
 
6.2.13 FCS 
 
The setup for FCS measurements consisted of a Leica TCS SP8 SMD microscope combined 
with a Picoquant LSM Upgrade Kit including the following devices: Sepia Multichannel 
Picosecond Diode Laser (PDL 808), Dual Channel Single Photon Avalanche Diodes (SPAD) 
detection unit, Dual SPAD power supply (DSN 102), 4 Channel Router (PHR 800) and a 
PicoHarp 300 TCSPC Module and Picosecond Event Timer (PH300). 
For all FCS measurements, a 63x Zeiss water immersion lens and ibidi 8 well µ-slides with 
glass bottoms were used. The effective volume (Veff) and structure parameter (κ) were 
precisely measured at the start of each experiment using a pure 1nM ATTO488 dye from 
ATTO-TEC GmbH. Three different points were measured in every cell nucleus for 45 s per 
point. This process was repeated for 4 different time points (0, 5, 15, 25 min) with the respective 
compound being added after the zero-time point measurement. 
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FCS curves were analyzed using the Picoquant SymPhoTime V 5.2.4.0 software. In detail, the 
FCS curves were fitted for 1 species using the triplet state (extended) model. Additionally, 
control FCS measurements without compounds were performed over the same time points to 
account for any bleaching effect on the GFP-actin in the cell over time. 
 
 
Figure 6-2 | FCS equations 
 
6.2.14 RICS 
 
RICS measurements were performed on a home-built PIE-FI microscope and calibrations were 
performed on single-measurement basis, as described elsewhere 144.  The following laser lines 
were used for excitation: 475 nm for GFP-actin and 561 nm for mCherry-actin. The laser power 
was measured using a slide power meter to be ~ 1.1 µW at the sample level. The 
measurements were performed using a 100x oil NA 1.49 objective. Image calculations from 
the raw photon data and subsequent analysis were performed with our Microtime Image 
Analysis (MIA) software. MIA is a stand-alone program (MATLAB; The MathWorks GmbH) for 
global, serial, and automated analysis of CLSM images (using continuous-wave excitation or 
PIE) that can perform RICS and ccRICS, as well as other image correlation methods. To 
localize the GFP- and mCherry-labeled actin, a wide-field imaging system was used. For 
prolonged imaging conditions at 37 °C, a home-built autofocus system was used to avoid the 
possible focal drift in z direction. The wide-field and autofocus systems are further described 
in 144. 
RICS and ccRICS were performed consecutively on the cytoplasm and on the nucleus. The 
data was obtained recording 150 frames per z position (12 × 12 μm or 300 × 300 pixels) at a 
frame time of τf = 1 s, interframe time τif = ∼ 0.5 s, line time τl = 3.33 ms, pixel dwell time τp = 
11.11 μs, and pixel size δr = 40 nm. The RICS and ccRICS processing was performed as 
explained elsewhere 144.  
The RICS experiments were corrected for cellular movement by applying a moving average 
correction prior to correlation of the image. For analyzing the different cellular regions, we 
designated an arbitrary ROI where the unwanted pixels (e.g. due to heterogeneities in the 
nucleus or from pixels outside of the cell) were removed. The correlation functions were then 
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determined using the ARICS algorithm. A two-component model assuming a 3D Gaussian 
focus shape was used for fitting the SACFs (eq. 2).   
 
 𝐺(𝜉, 𝜓) = ()*+, ∙ .1 + 12∙345678593:;< =>? ∙ .1 + 12∙345678593:@< =>A< ∙ exp E− GH<I4<78<J:;<712∙345678593K +()L** ∙ exp E− GH<I4<78<J:;<712∙345678593K				      (2) 
 
 
where ξ and ψ denote the spatial lag in pixels along the fast and the slow scanning axis, 
respectively. The scanning parameters: 𝜏O, 𝜏P, and 𝛿𝑟, represent the pixel dwell time, the line 
time (i.e. the time difference between the start of two consecutive lines), and the pixel size, 
respectively. 𝜔H and 𝜔T are the lateral and axial focus sizes, respectively, defined as the 
distance from the focus center to the point where the signal intensity has decreased to 1/e2 of 
the maximum. The shape factor 𝛾 is 2-3/2 for a 3D Gaussian. The vertical lines denote that the 
absolute value should be taken over the absolute time lag. The correlation at zero lag time was 
omitted from analysis due to the contribution of uncorrelated shot noise. 
The fitting was used to extract the quantitative number of mobile and immobile fraction of 
molecules. The “immobile” fraction refers to particles that did not move significant on the time 
necessary to image them (~ 30 ms), but are dynamic on the timescale of frames, otherwise 
they would have been removed by the moving average correction. A single, static-component 
was used for fitting the SCCFs (eq. 3) and used to extract the quantitative number of “immobile” 
molecules. 
 
 𝐺(𝜉, 𝜓) = ()L** ∙ exp E−GH<I(47VW)<7(87VX)<J:;<712∙345678593 K  (3) 
 
 
where sx and sy are the spatial offsets in x and y directions between the two images, 
respectively. 
The normalized fraction of polymerizing actin was obtained by the division of the SCCF 
amplitude by the SACF amplitude of the EGFP-labeled actin.  
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6.2.15 Statistical analysis 
 
All images and time lapse sequences were analyzed and processed using ImageJ version 1.5. 
Pearson correlation coefficients were calculated using the Coloc2 plugin for ImageJ according 
to the available online instructions. 
Statistical analysis (mean, standard deviation, standard error of the mean, unpaired student    
t-test, Sidak corrected one-way ANOVA test, Dunnett’s multiple comparisons test) was 
performed with GraphPad Prism Version 7.0a for Mac OS X.  
Unless stated otherwise, all data are derived from three independent experiments. 
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8 Appendix 
8.1 Supplementary Figures 
 
 
Figure S1 | FCS controls and 2 species fitting. (A) 2 species fit for EGFP-ß-actin diffusion coefficients and 
nuclear concentration after stimulation with Miuraenamide A. (B) 2 species fit for EGFP-ß-actin diffusion coefficients 
and nuclear concentration after stimulation with Latrunculin B. (C1) 1 species fit for EGFP-ß-actin diffusion 
coefficient and nuclear concentration in untreated control cells. (C2) 2 species fit for EGFP-ß-actin diffusion 
coefficients and nuclear concentration in untreated control cells. ≥ 40 cells were analyzed in for each of the three 
settings. Bars representing mean + SEM, statistical significance was determined by ordinary one-way ANOVA 
followed by Dunnett’s multiple comparisons test. 
 
 
  
0 5 15 25
0
10
20
30
40
time [min]
D 
[µ
m
2 /s
]
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
n.s.
0 5 15 25
0
2
4
6
8
10
time [min]
D 
[µ
m
2 /s
]
D1 (Miuraenamide A)
n.s.
0 5 15 25
0
20
40
60
time [min]
D 
[µ
m
2 /s
]
D2 (Miuraenamide A)
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
c (Miuraenamide A)
***
0 5 15 25
0
2
4
6
time [min]
D 
[µ
m
2 /s
]
D1 
n.s.
0 5 15 25
0
10
20
30
40
50
time [min]
D 
[µ
m
2 /s
]
D2 
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
n.s.
0 5 15 25
0
100
200
300
time [min]
c [
nM
]
c (Latrunculin B)
***
**
0 5 15 25
0
20
40
60
time [min]
D 
[µ
m
2 /s
]
D2 (Latrunculin B)
n.s.
0 5 15 25
0
2
4
6
time [min]
D 
[µ
m
2 /s
]
D1 (Latrunculin B)
n.s.
A 
B 
C1 
C2 
M
iu
ra
en
am
id
e 
A:
 2
 sp
ec
ie
s f
it 
La
tru
nc
ul
in
 B
: 2
 sp
ec
ie
s f
it 
Co
nt
ro
ls 
: 1
 sp
ec
ie
s f
it 
Co
nt
ro
ls 
: 2
 sp
ec
ie
s f
it 
8 Appendix 
  79 
 
 
Figure S2 | RICS analysis of nuclear versus cytoplasmatic actin polymerization in response to 
Miuraenamide A and Latrunculin B. (A) RICS data for the cytoplasmic (left) and nuclear (right) compartment 
upon the addition of 250 nM Latrunculin B. On the upper and lower left, the correlations along pixel lags (ξ,0) and 
(0, ψ) are shown, respectively. Blue and red curves represent the correlations before and 20 minutes after the 
addition of Latrunculin B. In the middle, the mean SACFs are depicted in 3D, color coded with the correlation values 
(the SACF before (top) and 20 minutes after the addition of Latrunculin B (bottom)). On the upper and lower right, 
the two-component fits of the data are shown before and 20 minutes after the addition of Latrunculin B. Fits are 
color coded according to the value of the goodness-of-fit weighted residuals parameter (W. Res.), where gray 
illustrates a good fit and red–blue indicates regions where the residuals deviate by > 5 σ. The same explanation 
applies for the nuclear data depicted in the right panels. (B) RICS data obtained for the cytoplasmic (left) and 
nuclear (right) compartments upon addition of 100 nM Miuraenamide. Further explanation applies as in (A). 
 
 
 
A 
B 
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Figure S3 | Time course of Fimm / Ftotal for EGFP-  and mCherry-ß-actin in the nuclear versus cytoplasmatic 
compartment in response to 100 nM Miuraenamide A or 250 nM Latrunculin B. 
 
 
 
 
 
Figure S4 | topGO analysis of gene expression for 0.5 U thrombin versus control. Cells were stimulated for 
4 h. The numbers in each bar indicate the number of enriched genes over the number of annotated genes in this 
term. Asterisks show the level of significance of Fisher'ś exact test for the enrichment of the particular term.             
* p-value < 0.01; ** p-value < 0.001; *** p-value < 0.0001. 
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8.3 Abbreviations 
 
Table 9 List of abbreviations 
Abbreviation Full name 
°C degree celsius 
2D two-dimensional 
3D three-dimensional 
AMOT angiomotin 
ANOVA analysis of variance 
BSA bovine serum albumin 
cDNA complementary DNA 
cm centimeter 
CSB cytoskeleton stabilizing buffer 
DNA deoxyribonucleic acid 
ECD extracellular domain 
EGFP enhanced green fluorescent protein 
EM electron microscopy 
FCS (1) fetal calf serum 
FCS (2) fluorescence correlation spectroscopy 
FDR false discovery rate 
GFP green fluorescent protein 
GLM generalized linear model 
h hour 
HA hemagglutinin 
Hertz Hz 
HRP horseradish peroxidase 
HyD hybrid detector 
IB4 isolectin B4 
IF immunofluorescence 
kDA kilodalton 
LINC linker of the nucleoskeleton and the cytoskeleton 
luc luciferase 
MAL megakaryotic acute leukemia 
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Abbreviation Full name 
mg milligram 
min minute 
ml milliliter 
mM millimolar 
mRNA messenger RNA 
MRTF myocardin related transcription factor 
nAC nuclear actin chromobody 
NES nuclear export signal 
ng nanogram 
NLS nuclear localization signal 
nm nanometer 
nM nanomolar 
PBS phosphate buffered saline 
PDMS polydimethylsiloxane 
PEG polyethylene glycol 
PLL poly-L-lysine 
PVDF Polyvinylidene difluoride 
RFP red fluorescent protein 
RICS raster image correlation spectroscopy 
RLU relative light units 
RNA ribonucleic acid 
rpm rotations per minute 
rRNA ribosomal RNA 
RT room temperature 
s second 
SD standard deviation 
SEM standard error of the mean 
SMD single molecule detection 
SRE serum response element 
SRF serum response factor 
TAZ transcriptional coactivator with PDZ binding motif 
TCF ternary complex factor 
TEAD TEF-1, TEC1, ABAA domain 
V Volt 
YAP yes-associated protein 
YFP yellow fluorescent protein 
µCP microcontact printing 
µg microgram 
µl microliter 
µm micrometer 
µM micromolar 
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